US20170086713A1 - System for monitoring body chemistry - Google Patents
System for monitoring body chemistry Download PDFInfo
- Publication number
- US20170086713A1 US20170086713A1 US15/377,318 US201615377318A US2017086713A1 US 20170086713 A1 US20170086713 A1 US 20170086713A1 US 201615377318 A US201615377318 A US 201615377318A US 2017086713 A1 US2017086713 A1 US 2017086713A1
- Authority
- US
- United States
- Prior art keywords
- user
- housing portion
- microsensor
- applicator
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000012544 monitoring process Methods 0.000 title claims abstract description 52
- 239000012491 analyte Substances 0.000 claims abstract description 75
- 238000012545 processing Methods 0.000 claims abstract description 40
- 238000004458 analytical method Methods 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 29
- 210000003722 extracellular fluid Anatomy 0.000 claims abstract description 13
- 238000010168 coupling process Methods 0.000 claims description 36
- 238000005859 coupling reaction Methods 0.000 claims description 36
- 230000008878 coupling Effects 0.000 claims description 35
- 238000004891 communication Methods 0.000 claims description 27
- 239000000758 substrate Substances 0.000 claims description 24
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 12
- 230000007246 mechanism Effects 0.000 claims description 12
- 230000004044 response Effects 0.000 claims description 11
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 230000007704 transition Effects 0.000 claims description 5
- 210000000746 body region Anatomy 0.000 claims 2
- 230000009365 direct transmission Effects 0.000 claims 2
- 230000001133 acceleration Effects 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 230000003750 conditioning effect Effects 0.000 abstract description 14
- 230000006870 function Effects 0.000 description 45
- 238000001514 detection method Methods 0.000 description 35
- 238000007726 management method Methods 0.000 description 29
- 210000003491 skin Anatomy 0.000 description 19
- 230000036541 health Effects 0.000 description 16
- 238000005259 measurement Methods 0.000 description 15
- 239000010410 layer Substances 0.000 description 13
- 230000005540 biological transmission Effects 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 238000013500 data storage Methods 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 6
- 239000012482 calibration solution Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 238000009877 rendering Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 238000013478 data encryption standard Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 230000000284 resting effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- -1 cell count Substances 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002847 impedance measurement Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910001416 lithium ion Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 230000005800 cardiovascular problem Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013079 data visualisation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0538—Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
- A61B5/6849—Needles in combination with a needle set
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/685—Microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6879—Means for maintaining contact with the body
- A61B5/688—Means for maintaining contact with the body using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7278—Artificial waveform generation or derivation, e.g. synthesising signals from measured signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7285—Specific aspects of physiological measurement analysis for synchronising or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Y—INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]
- G16Y10/00—Economic sectors
- G16Y10/60—Healthcare; Welfare
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W12/00—Security arrangements; Authentication; Protecting privacy or anonymity
- H04W12/03—Protecting confidentiality, e.g. by encryption
- H04W12/037—Protecting confidentiality, e.g. by encryption of the control plane, e.g. signalling traffic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
- A61B2562/0214—Capacitive electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/028—Microscale sensors, e.g. electromechanical sensors [MEMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/164—Details of sensor housings or probes; Details of structural supports for sensors the sensor is mounted in or on a conformable substrate or carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6885—Monitoring or controlling sensor contact pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Y—INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE INTERNET OF THINGS [IoT]
- G16Y40/00—IoT characterised by the purpose of the information processing
- G16Y40/10—Detection; Monitoring
Definitions
- This invention relates generally to the biometric device field, and more specifically to a new and useful system for monitoring body chemistry in the biometric device field.
- Biomonitoring devices are commonly used, particularly by health-conscious individuals and individuals diagnosed with ailments, to monitor body chemistry. Such biomonitoring devices perform the tasks of determining an analyte level in a user's body, and providing information regarding the analyte level to a user; however, these current biomonitoring devices typically convey information to users that is limited in detail, intermittent, and prompted by the command of the user. Such biomonitoring devices, including blood glucose meters, are also inappropriate for many applications outside of intermittent use, and place significant burdens on users (e.g., in requiring finger sticks, in requiring lancing, etc.) due to design and manufacture considerations. Additionally, current devices are configured to analyze one or a limited number of analytes contributing to overall body chemistry, due to limitations of sensors used in current biomonitoring devices.
- FIG. 1 depicts elements of an embodiment of a system for monitoring body chemistry
- FIGS. 2A and 2B depict embodiments of a microsensor patch, a transmitting unit, a housing, and an array of filaments in an embodiment of a system for monitoring body chemistry;
- FIG. 2C depict a variation of electrodes in an embodiment of a system for monitoring body chemistry
- FIGS. 3A-3H depict examples of filament variations in an embodiment of a system for monitoring body chemistry
- FIG. 4 depicts an embodiment of an electronics subsystem in an embodiment of a system for monitoring body chemistry
- FIGS. 6A-6B depict examples of power management modules in an embodiment of a system for monitoring body chemistry
- FIG. 7 depicts a variation of an impedance detection module in an embodiment of a system for monitoring body chemistry
- FIG. 8 depicts an example of an applied voltage waveform in an embodiment of a system for monitoring body chemistry
- FIG. 9 depicts a variation of a housing in an embodiment of a system for monitoring body chemistry
- FIG. 10C depicts a specific portion of a housing in an embodiment of a system for monitoring body chemistry
- FIG. 12A depicts a notification module of an embodiment of a system for monitoring body chemistry
- FIG. 13 depicts communication between a processing subsystem and a storage module in an embodiment of a system for monitoring body chemistry
- FIGS. 14A-14C depict examples of an arch application method and an end-to-end application method, respectively, in an embodiment of a system for monitoring body chemistry
- FIGS. 15A-15B depict variations of a patch applicator in an embodiment of a system for monitoring body chemistry
- FIGS. 16A-16D depict a first specific example of a patch applicator in an embodiment of a system for monitoring body chemistry
- FIG. 17 depicts a second specific example of a patch applicator in an embodiment of a system for monitoring body chemistry
- FIGS. 18A-18B depict a specific example of a base station in an embodiment of a system for monitoring body chemistry
- FIG. 19 depicts operation modes of components of an embodiment of a system for monitoring body chemistry.
- FIG. 20 depicts an embodiment of a method for monitoring body chemistry.
- an embodiment of the system 100 for monitoring body chemistry of a user comprises a housing 190 that supports a microsensor 116 and an electronics subsystem 120 in communication with the microsensor 116 ; and a processing subsystem 160 configured to generate an analysis indicative of an analyte parameter of the user, wherein the analysis is derived from a signal stream of the microsensor and an impedance signal from the electronics subsystem.
- the housing 190 , microsensor 116 , and the electronics subsystem 120 can be configured as a microsensor patch 110 configured to sense analyte levels in a user's body, wherein the electronics subsystem includes a signal conditioning module 122 , a power management module 124 , a storage module 127 , and a transmitting unit 130 in communication with the processing subsystem 160 and/or an electronic device (e.g., mobile computing device iso) associated with the user.
- an electronic device e.g., mobile computing device iso
- the system 100 can further include a patch applicator 180 configured to facilitate application of the microsensor patch 110 onto the body of a user in a reliable manner.
- the system 100 functions to provide continuous monitoring of a user's body chemistry through reception and processing of signals associated with one or more analytes present in the body of the user, and to provide an analysis of the user's body chemistry to the user and/or an entity (e.g., health care professional, caretaker, relative, friend, acquaintance, etc.) associated with the user.
- the system 100 can function to detect a user's body chemistry upon the user's request or sporadically, and/or can provide an analysis of the user's body chemistry only to the user.
- the system 100 is configured to be worn by the patient outside of a clinical (e.g., hospital) or research (e.g., laboratory) setting, such that the patient can be in a non-contrived environment as he or she is interfacing with the microsensor patch 110 for monitoring of body chemistry.
- elements of the system 100 can be reusable or disposable (e.g., based upon modularity of the system 100 ), or the entire system 100 can be configured to be disposable.
- the system 100 adheres to the patient (thus not compelling the patient to hold any part of the system 100 by hand), has a low profile that conforms to the patient, and is configured to receive and transmit signals indicative of body chemistry parameters of the user, for downstream analysis and information transfer to the user.
- the system 100 can be substantially non-portable, non-wearable, and/or intended for use in a clinical or research setting.
- elements of the system can be implemented on one or more computer networks, computer systems, or applications servers, etc.
- the computer system(s) can comprise one or more of: a cloud-based computer, a mainframe computer system, a grid-computer system, or any other suitable computer system, and the computer system can support collection of data from a wearable device and/or a base station, processing of these data, and transmission of alerts, notifications, and/or user interface updates to one or more electronic computing devices (e.g., mobile computing device, wrist-borne mobile computing device, head-mounted mobile computing device, etc.) linked to or affiliated with an account of the user.
- electronic computing devices e.g., mobile computing device, wrist-borne mobile computing device, head-mounted mobile computing device, etc.
- the computer system can receive signals indicative of one or more analyte parameters of the user and distribute alerts and notifications over a distributed network, such as over a cellular network or over an Internet connection.
- the computer system can upload alerts and notifications to a native body chemistry monitoring application including the user interface and executing on a mobile computing device associated with the user.
- an electronic computing device e.g., a laptop computer, a desktop computer, a tablet, a smartphone, a smart watch, a smart eyewear accessory, a personal data assistant, etc.
- an electronic computing device e.g., a laptop computer, a desktop computer, a tablet, a smartphone, a smart watch, a smart eyewear accessory, a personal data assistant, etc.
- a native body chemistry monitoring application including the user interface
- functions including one or more of: generating alerts or notifications, receiving alerts or notifications, displaying alerts or notifications, updating predictions of changes in state of the user, and any other suitable function that enhances body chemistry monitoring of the user.
- the system 100 is preferably configured to implement at least a portion of the method 200 described in Section 2 below; however, the system 100 can additionally or alternatively be configured to implement any other suitable method.
- the microsensor patch 110 comprises a microsensor 116 and an electronics subsystem 120 in communication with the microsensor 116 , wherein the microsensor 116 and the electronics subsystem 120 are supported by a housing 190 .
- the microsensor patch 110 can be configured to detect and sense only a single analyte; however, the microsensor patch no can alternatively be configured to detect and sense multiple analytes in order to provide an analysis based on multiple analytes.
- the microsensor patch no is configured to be disposable; however, the microsensor patch no can alternatively be configured to be reusable for any suitable duration or number of uses.
- the microsensor patch 110 is configured to be a semi-permanent component (e.g., wearable for a week before replacement, wearable for a month before replacement, etc.) configured to sense the user's body chemistry with minimal signal degradation for at a least a week post-coupling of the microsensor patch no to the body of the user.
- the microsensor patch 110 can be configured to be a permanent component configured to permanently couple to a user. Modularity of the microsensor patch 110 is described in further detail below.
- the microsensor 116 of the microsensor patch no preferably comprises an array of filaments 117 , as shown in FIGS. 1 and 2A , and functions to penetrate skin of the user in order to sense one or more analytes characterizing the user's body chemistry.
- the array of filaments 117 is configured to penetrate the user's stratum corneum (i.e., an outer skin layer) in order to sense analytes within interstitial (extracellular) fluid, which is throughout the body; however, the array of filaments 117 can be configured to penetrate the user's skin to any other suitable depth.
- the microsensor 116 can alternatively be configured to penetrate deeper layers, or various depth layers of a user's skin in order to sense analytes within any appropriate bodily fluid of the user.
- the microsensor 116 can be configured to sense analytes/ions characterizing a user's body chemistry using a potentiometric measurement (e.g., for small analytes including potassium, sodium calcium, etc.), using an amperometric measurement (e.g., for large analytes including glucose, lactic acid, creatinine, etc.), using a conductometric measurement, and/or using any other suitable measurement.
- sensed analytes result in a signal (e.g., voltage, current, resistance, capacitance, impedance, gravimetric, etc.) detectable by the electronics subsystem 120 in communication with the microsensor 116 ; however, analyte sensing can comprise any other appropriate mechanism using the microsensor 116 .
- the microsensor 116 is also preferably integrated with the electronics subsystem 120 .
- the microsensor 116 is coupled to the semiconductor architecture of the electronics subsystem 120 (e.g., the microsensor 116 is coupled to an integrated circuit comprising the electronics subsystem 120 ), in a second variation, the microsensor 116 is more closely integrated into the semiconductor architecture of the electronics subsystem 120 (e.g., there is closer integration between the microsensor 116 and an integrated circuit including the electronics subsystem 120 ), and in a third variation, the microsensor 116 and the electronics subsystem 120 are constructed in a system-on-a-chip fashion (e.g., all components are integrated into a single chip).
- filaments the array of filaments 117 of the microsensor 116 can be directly or indirectly integrated with electronics components, such that preprocessing of a signal from the microsensor 116 can be performed using the electronics components (e.g., of the array of filaments 117 , of the electronics subsystem 120 ) prior to or after transmitting signals to the electronics subsystem 120 (e.g., to an analog front end, to an analog to digital converter).
- the electronics components can be coupled to a filament substrate, or otherwise integrated with the filaments in any suitable fashion (e.g., wired, using a contact pad, etc.).
- the electronics components can be fully integrated into the electronics subsystem 120 and configured to communicate with the microsensor 116 , or the electronics components can be split between the microsensor and the electronics subsystem 120 .
- the microsensor 116 can, however, comprise any other suitable architecture or configuration.
- the microsensor 116 preferably senses analyte parameters using the array of filaments 117 , such that absolute values of specific analytes/ions can be detected and analyzed.
- the microsensor 116 can additionally be configured to sense analyte parameters using the array of filaments 117 , such that changes in values of specific analyte/ion parameters or derivatives thereof (e.g., trends in values of a parameter, slopes of curves characterizing a trend in a parameter vs. another parameter, areas under curves characterizing a trend, a duration of time spent within a certain parameter range, etc.) can be detected and analyzed.
- changes in values of specific analyte/ion parameters or derivatives thereof e.g., trends in values of a parameter, slopes of curves characterizing a trend in a parameter vs. another parameter, areas under curves characterizing a trend, a duration of time spent within a certain parameter range, etc.
- sensing by the microsensor 116 is achieved at a low frequency at discrete time points (e.g., every minute, or every hour), and in another variation, sensing by the microsensor 116 is achieved substantially continuously at a high frequency (e.g., every picosecond, every millisecond, every second).
- the array of filaments 117 of the microsensor 116 is configured to sense one or more of: electrolytes, glucose, bicarbonate, creatinine, body urea nitrogen (BUN), sodium, iodide, iodine and potassium of a user's blood chemistry.
- the array of filaments 117 of the microsensor 116 is configured to sense at least one of biomarkers, cell count, hormone levels, alcohol content, gases (e.g. carbon dioxide, oxygen, etc.), drug concentrations/metabolism, pH and analytes within a user's body fluid.
- biomarkers e.g. biomarkers, cell count, hormone levels, alcohol content, gases (e.g. carbon dioxide, oxygen, etc.), drug concentrations/metabolism, pH and analytes within a user's body fluid.
- the array of filaments 117 is preferably located at the base surface of the microsensor patch 110 , and functions to interface directly with a user in a transdermal manner (e.g., in accessing interstitial fluid) in order to sense at least one analyte/ion characterizing the user's body chemistry.
- the array of filaments 117 is preferably arranged in a uniform pattern with a specified density optimized to effectively penetrate a user's skin and provide an appropriate signal, while minimizing pain to the user. Additionally, the array of filaments 117 can be arranged in a manner to optimize coupling to the user, such that the microsensor firmly couples to the user over the lifetime usage of the system.
- the filaments 118 can comprise several pieces and/or be attached to a flexible base to allow the array of filaments 117 to conform to a user's body.
- the array of filaments 117 is arranged in a rectangular pattern, and in another variation, the array of filaments 117 is arranged in a circular or ellipsoid pattern.
- the array of filaments 117 can be arranged in any other suitable manner (e.g., a random arrangement).
- the array of filaments 117 can also be configured to facilitate coupling to a user, by comprising filaments of different lengths or geometries.
- filaments 118 of different lengths can further function to allow measurement of different ions/analytes at different depths of penetration (e.g., a filament with a first length can sense one analyte at a first depth, and a filament with a second length can sense another analyte at a second depth).
- the array of filaments 117 can also comprise filaments 118 of different geometries (e.g., height, diameter) to facilitate sensing of analytes/ions at lower or higher concentrations.
- the array of filaments 117 is arranged at a density of 100 filaments per square centimeter and each filament 118 in the array of filaments 117 has a length of 250-350 microns, which allows appropriate levels of detection, coupling to a user, and pain experienced by the user.
- Each filament 118 in the array of filaments 117 preferably functions to sense a single analyte; however, each filament 118 in the array of filaments 117 can additionally be configured to sense more than one analyte. Furthermore, the array of filaments 117 can be further configured, such that a subarray of the array of filaments 117 functions as a single sensor configured to sense a particular analyte or biomarker, as shown in FIG. 2B .
- any configuration of subarrays of the array of filaments 117 can additionally or alternatively be configured as one or more of: a working electrode, a counter electrode (i.e., auxiliary electrode), and a reference electrode, for instance, in a two-electrode cell, a three-electrode cell, or a more-than-three-electrode cell.
- a working electrode i.e., a counter electrode
- a reference electrode for instance, in a two-electrode cell, a three-electrode cell, or a more-than-three-electrode cell.
- the array of filaments 117 of the microsensor 116 is configured as a first working electrode 11 (corresponding to a first subarray of filaments), a second working electrode 12 (corresponding to a second subarray of filaments), a counter electrode 13 (corresponding to a third subarray of filaments), and a reference electrode 14 (corresponding to a fourth subarray of filaments).
- each subarray associated with the first working electrode 11 , the second working electrode 12 , the counter electrode 13 , and the reference electrode 14 is substantially identical in morphology (e.g., area of the microsensor).
- each subarray has a square footprint
- the subarrays are configured in a 2 ⁇ 2 arrangement to define a larger square footprint.
- the array of filaments 117 can be configured as one or more of: a working electrode, a counter electrode, and a reference electrode in any other suitable manner, and can furthermore have any other suitable morphology(ies) and/or configuration relative to each other.
- any subarray of the array of filaments 117 can be configured to release biomaterials (e.g., therapeutic substances, drugs) for treating a medical condition of a user (e.g., as facilitated by biomaterial dissolution in interstitial fluid). Multiple subarrays of the array of filaments can then be configured to sense different analytes/biomarkers, or the same analyte/biomarker. Furthermore, a subarray or a single filament 118 of the array of filaments 117 can be configured as a ground region of the microsensor 116 , such that signals generated by the microsensor 116 in response to analyte detection can be normalized by the signals generated by the subarray or single filament 118 serving as a ground region.
- biomaterials e.g., therapeutic substances, drugs
- all subarrays of the array of filaments 117 are substantially equal in size and density; however, each subarray of the array of filaments 117 can alternatively be optimized to maximize signal generation and detection in response to a specific analyte.
- analytes that are known to have a lower concentration within a user's body fluid can correspond to a larger subarray of the array of filaments 117 .
- analytes that are known to have a higher concentration within a user's body fluid can correspond to a smaller subarray of the array of filaments 117 .
- an entire array of filaments can be configured to sense a single analyte, such that the microsensor 116 and microsensor patch 110 is configured to sense and detect only one analyte.
- each single filament in an array can be configured to detect a single analyte allowing for detection of multiple analytes within a single array (e.g., for a 100-filament array, 100 analytes can be tested).
- a subarray of the array of filaments 117 can also be used to detect other physiologically relevant parameters, such as electrophysiological signals (e.g., electrocardiogram, electroencephalogram), body temperature, respiration, and skin impedance change (e.g., to measure hydration state or inflammatory response).
- the subarray can be dedicated to measuring these physiologically relevant parameters, which could be combined with analyte/ion parameter measurements in order to provide meaningful information to a user.
- the simultaneous measurement of potassium levels and electrocardiogram measurements, enabled by subarrays of the array of filaments 117 can provide a more complete diagnosis of cardiovascular problems or events than either measurement by itself.
- a filament 118 of the array of filaments can comprise one or more of: a substrate core, the substrate core including a base end coupled to the substrate, a columnar protrusion having a proximal portion coupled to the base end and a distal portion, and a tip region coupled to the distal portion of the columnar protrusion and that facilitates access to the body fluid of the user; a conductive layer, isolated to the tip region of the substrate core and isolated away from the base end and the columnar protrusion as an active region that enables transmission of electronic signals generated upon detection of an analyte; an insulating layer ensheathing the columnar protrusion and base end of the substrate core and exposing a portion of the conductive layer, thereby defining a boundary of the active region; a sensing layer, in communication with the active region, characterized by reversible redox behavior for transduction of an ionic concentration of the analyte into an electronic signal; an intermediate selective layer superficial to the conductive layer and deeper than the sensing layer
- a filament can comprise one or more regions, morphologies (examples of which are shown in FIGS. 3A-3H , with elements 118 a - 118 h ), compositions, and/or configurations as described in U.S. Pub. No. 2014/0275897, entitled “On-Body Microsensor for Biomonitoring” and filed on 14 Mar. 2014 and/or U.S. App. No. 62/025,174, and entitled “System for Monitoring Body Chemistry” and filed on 16 Jul. 2014, which are each incorporated herein in their entirety by this reference.
- the filament can additionally or alternatively comprise any other suitable region, composition, morphology, and/or configuration.
- the microprocessor 113 preferably includes memory and/or is coupled to a storage module 127 (e.g., flash storage).
- the microprocessor 113 can also include and/or be coupled to a clock/watchdog module (which can be incorporated into a microcontroller unit) for control of timing between different functions of the electronics subsystem 120 .
- the microprocessor 113 functions to process received signals, enable power distribution, enable impedance monitoring, and enable data transmission from the electronics subsystem 120 , in relation to other portions of the electronics subsystem 120 described below; however, the microprocessor 113 can alternatively or additionally be configured to perform any other suitable function.
- the signal conditioning module 122 functions to preprocess signals detected and received using the microsensor 116 , thereby producing conditioned data prior to processing at the processing subsystem 160 .
- the signal conditioning module 122 can include one or more of: a signal multiplexer, an analog front end, an amplifier (e.g., a variable gain amplifier), a filter (e.g., low pass filter, high pass filter, band pass filter, etc.), an analog-to-digital converter (ADC), and a digital-to-analog converter (DAC).
- a signal multiplexer e.g., a variable gain amplifier
- a filter e.g., low pass filter, high pass filter, band pass filter, etc.
- ADC analog-to-digital converter
- DAC digital-to-analog converter
- the signal conditioning module 122 comprises a multiplexer 22 in communication with the microsensor 116 , wherein the multiplexer 22 is configured to communicate an output to an analog front end 23 that interfaces the microsensor 116 with an ADC 24 by way of a variable gain amplifier 25 coupled to a filter 26 .
- the analog front end 23 circuitry is configured with a shifted potential different than a reference potential of the reference electrode 14 of the microsensor 116 , wherein the shifted potential is different (e.g., ⁇ 2V to 2V different) from the reference potential of the reference electrode 14 .
- the configuration involving a difference between the shifted potential and the reference potential can allow the system 100 to drive redox reactions at the surface of the microsensor 110 .
- the analog front end (or any other element of the signal conditioning module 122 ) can be configured with any other suitable potential relative to potentials of electrodes of the microsensor 116 .
- the multiplexer 22 of the signal conditioning module 122 is preferably configured to receive multiple signals from the microsensor 116 (e.g., from subarrays of the array of filaments 117 ) and to forward the multiple signals received at multiple input lines in a single line at the analog front end.
- the multiplexer 22 thus increases an amount of data that can be transmitted within a given time constraint and/or bandwidth constraint.
- the number of input channels to the multiplexer 22 is preferably greater than or equal to the number of output channels of the microsensor 116 , and can have any suitable relationship between the number of input lines into the multiplexer 22 , select lines of the multiplexer, and output lines from the multiplexer 22 .
- the multiplexer 22 can include a post-multiplexer gain in order to reduce capacitance values of the analog front end 23 coupled to the multiplexer 22 , and which can also be used to limit a number of amplifiers of the electronics 120 , such that a single amplifier is coupled to the multiplexer 22 (as opposed to amplifiers coupled to each individual sensor); however, the multiplexer 22 can alternatively not include any gain producing elements.
- the multiplexer 22 can additionally or alternatively include high frequency and/or low frequency limiting elements.
- the multiplexer 22 can additionally or alternatively be configured in any other suitable manner.
- the signal conditioning module 122 can omit a multiplexer and/or comprise or omit any other suitable element.
- power management can be achieved by the power management module 124 without implementation in firmware, such that power management occurs in circuitry.
- power management can comprise providing a set amount of power to elements requiring power, and completely eliminating power transfer to elements not requiring power.
- the system 100 can, however, comprise any other suitable variation of the power management modules 124 .
- the electronics subsystem 120 can comprise a battery 138 , which functions to serve as a power source for the electronics subsystem 120 .
- the battery 138 is preferably coupled to a fuel gage 38 and a charging detection module 39 , each of which is coupled to the microprocessor 113 (described in further detail below).
- the battery 138 is preferably a lithium-ion battery that is configured to be rechargeable, but can be any appropriate rechargeable battery (e.g., nickel-cadmium, nickel metal hydride, or lithium-ion polymer). Alternatively, the battery 138 may not be a rechargeable battery.
- the microsensor patch 110 can comprise a semi-active or fully-active power cell (e.g., implementing microelectromechanical system elements) that functions to absorb and/or release generated energy from any one or more of: body heat of the user, body movement of the user (e.g., with piezoelectric elements, with capacitive elements), static voltage from the environment of the user, light in the environment of the user (e.g., using solar cells), magnetic energy flux, galvanic differentials, and any other suitable energy source to provide secondary backup energy for the system 100 .
- a semi-active or fully-active power cell e.g., implementing microelectromechanical system elements
- body movement of the user e.g., with piezoelectric elements, with capacitive elements
- static voltage from the environment of the user e.g., with light in the environment of the user (e.g., using solar cells), magnetic energy flux, galvanic differentials, and any other suitable energy source to provide secondary backup energy for the system 100 .
- the impedance detection module 126 is in communication with the signal conditioning module 122 and the power management module 124 , and functions to enable detection of a proper interface between the microsensor 116 and body fluid (e.g., interstitial fluid) of the user. In facilitating monitoring of impedance, the impedance detection module 126 can thus provide signals that indicate that the microsensor patch 110 is properly coupled to the user (e.g., interfacing with interstitial fluid and experiencing an ⁇ 80% moisture environment) or improperly coupled to the user (e.g., not interfacing properly with interstitial fluid and experiencing a low-moisture environment).
- Signals from the impedance detection module 126 can further be used to trigger an error correction action (e.g., notification for the user to reapply the microsensor patch 110 , automatic manipulation of the microsensor patch 110 to re-establish interface with body fluid, etc.).
- the impedance detection module can comprise electronic circuitry configured to communicate with the multiplexer 22 , the ADC 24 , and the power management module 124 , in receiving an impedance signal from the microsensor 116 .
- the impedance detection module 126 can additionally or alternatively be configured relative to other elements of the electronics subsystem 120 in any other suitable manner.
- the impedance detection module 126 can be configured to detect impedance between two electrodes of the array of filaments 117 in response to an applied voltage provided in cooperation with the power management module 126 and the microprocessor 113 .
- the impedance detection module 126 can be configured to detect impedance from two of the first working electrode 11 , the second working electrode 12 , the counter electrode 13 , and the reference electrode 14 , examples of which are shown in FIG. 7 .
- an applied signal can be injected into the system in a working electrode and detected in the reference electrode 14 .
- the impedance detection module 126 can be configured to detect impedance from electrodes of the microsensor 116 in any other suitable manner.
- the electronics subsystem 120 is preferably configured to provide an applied voltage waveform having a characteristic value (e.g., average value) near the operating potential of the signal conditioning module 122 of the electronics subsystem 120 .
- a characteristic value e.g., average value
- the signal conditioning module 122 (e.g., an analog front end 23 of the signal conditioning module 122 ) operates at a shifted potential relative to a potential of an electrode of the microsensor 116 (e.g., a reference potential of a reference electrode)
- the applied voltage waveform preferably has a characteristic value (e.g., average value) near or equal to that of the shifted potential, in order to improve stability of the microsensor no when switching back to a current sensing mode (i.e., the primary detection mode).
- the offset i.e., shifted potential
- the applied voltage waveform is shifted about a characteristic value and has a frequency from 50-200 kHz, in relation to a shifted potential of the analog front end 23 relative to the reference electrode 14 .
- the applied voltage can alternatively have any other suitable characteristics (e.g., characteristic voltage values, frequencies, etc.) defined in relation to the operating potential(s) of any other suitable element of the electronic subsystem 120 related to the microsensor 116 .
- the electronics subsystem 120 and the processing subsystem 160 can be configured to cooperate in continuously detecting a voltage parameter of the counter electrode 13 , and the electronics subsystem 120 can be configured to apply the applied voltage waveform and detect the impedance signal when the voltage parameter of the counter electrode satisfies a voltage threshold condition.
- the impedance detection module 126 can be configured to provide an impedance signal upon initial application of the system 100 to the body of the user. Additionally or alternatively, in another variation, the impedance detection module 126 can be configured to provide impedance signals at regular time intervals (e.g., once every hour) over the course of use of the system 100 by the user. Additionally or alternatively, in relation to other sensors (e.g., of a mobile computing device associated with the user and the system 100 , of a wearable computing device associated with the user and the system 100 , of the system 100 , etc.) the impedance detection module 126 can be configured to provide an impedance signal in response to a sensor signal that indicates performance of an action by the user.
- sensors e.g., of a mobile computing device associated with the user and the system 100 , of a wearable computing device associated with the user and the system 100 , of the system 100 , etc.
- the impedance detection module 126 can further be used to generate notifications pertaining to impedance signal measurements that indicate improper coupling. For instance, a notification can be generated (and transmitted to a mobile computing device of the user) in response to detection of unsuitable impedance derived from comparison between the impedance signal and an impedance threshold condition.
- a notification can be generated (and transmitted to a mobile computing device of the user) in response to detection of unsuitable impedance derived from comparison between the impedance signal and an impedance threshold condition.
- use of the impedance signal in performing an error correction action can be performed in any other suitable manner.
- the transmitting unit 130 functions to receive signals generated by the microsensor patch 110 (e.g., by way of the microprocessor 113 ), and to interface with at least one of a mobile computing device 150 , a data processing and/or storage module (e.g., a module external to an on-board storage module, a cloud-based computing module, etc.) by outputting signals based on at least one analyte parameter.
- the transmitting unit 130 thus cooperates with other elements of the electronics subsystem 120 to transmit signals based on sensed analyte parameters, which can be used to facilitate analyses of the user's body chemistry.
- the transmitting unit 130 includes an antenna 132 , a radio 134 coupling the antenna to the microprocessor 113 , and can additionally or alternatively include a linking interface 136 (e.g., wireless or wired interface, as described in further detail below).
- a linking interface 136 e.g., wireless or wired interface, as described in further detail below.
- the transmitting unit 130 and the microsensor patch no are integrated as a cohesive unit; however, the transmitting unit 130 and the microsensor patch no can alternatively form a modular unit, wherein one of the transmitting unit 130 and the microsensor patch 110 is disposable, and wherein one of the transmitting unit 130 and the microsensor patch no is reusable.
- elements of the microsensor patch no aside from the microsensor 116 can alternatively be integrated with the transmitting unit 130 , such that the transmitting unit 130 is configured to be reusable and the microsensor 116 of the microsensor patch 110 is configured to be disposable. Modularity in the system 100 is described in further detail in relation to the housing 190 below.
- the transmitting unit 130 is preferably configured to output signals based on at least one analyte parameter characterizing body chemistry continuously over the lifetime usage of the transmitting unit 130 ; however, the transmitting unit 130 can alternatively be configured to output signals based on at least one analyte parameter at a set of time points (e.g., minutes, hours, days). Still alternatively, the transmitting unit 130 can be configured to output signals in a manner that does not interfere with other operations (e.g., signal collection operations) of the electronics subsystem 120 . In one such example, the transmitting unit 130 can be configured to stop signal transmission whenever the ADC 24 is collecting signal data from the microsensor 116 , in coordination with timing enabled by a clock/watchdog module associated with the microprocessor 113 .
- the transmitting unit 130 can be further configured to output signals upon a user prompt, and/or can comprise a variable sampling rate.
- the sampling rate can be lower when user is asleep, higher during activity (e.g., exercise), higher when there is a sudden change in a value, higher in response to other stimuli (e.g., if glucose spikes, sampling rate increases for all analytes).
- the antenna 132 of the transmitting unit 130 functions to convert electrical signals from the microsensor patch no into radio waves, to facilitate communication with one or more devices external to the microsensor patch no and/or transmitting unit 130 assembly (e.g., by a Bluetooth Low Energy connection).
- the antenna 132 preferably interfaces with a radio 134 coupled to the microprocessor 113 , as shown in FIG. 4 , but can additionally or alternatively interface with other elements of the transmitting unit 130 .
- the antenna is preferably an omnidirectional antenna that radiates radio wave power uniformly primarily in one plane, with the power decreasing with elevation angle relative to the plane; however, the antenna can alternatively be an isotropic antenna that has a spherical radiation patent.
- Other variations of the antenna can include any appropriate antenna that can be integrated with the form factor of the transmitting unit, while providing appropriate communication with external devices.
- the radio 134 functions to transmit and receive signals from the antenna 132 , and also facilitates communication with elements of the transmitting unit 130 and external devices.
- the radio 134 and the antenna 132 can additionally or alternatively be supplemented with a linking interface 136 , as described in further detail below, but can additionally or alternatively interface with other elements of the electronics subsystem 120 .
- the linking interface 136 functions to transmit an output of at least one element of the microsensor patch no/transmitting unit 130 assembly to a mobile computing device 150 . Additionally, the linking interface 136 can function to transmit and output of at least one element of the microsensor patch 110 and transmitting unit 130 assembly to another element external to the microsensor patch 110 and transmitting unit 130 . Preferably, the linking interface 136 is a wireless interface; however, the linking interface 136 can alternatively be a wired connection.
- the linking interface 136 can include a first module that interfaces with a second module included in a mobile computing device 150 or other external element (e.g., wrist-borne mobile computing device, head-mounted mobile computing device), wherein data or signals (e.g., microsensor or transceiver outputs) are transmitted from the transmitting unit 130 to the mobile computing device 150 or external element over non-wired communications.
- the linking interface 136 of the first variation can alternatively implement other types of wireless communications, such as 3G, 4G, radio, or Wi-Fi communication.
- data and/or signals are preferably encrypted before being transmitted by the linking interface 136 .
- cryptographic protocols such as Diffie-Hellman key exchange, Wireless Transport Layer Security (WTLS), or any other suitable type of protocol can be used.
- the data encryption can also comply with standards such as the Data Encryption Standard (DES), Triple Data Encryption Standard (3-DES), or Advanced Encryption Standard (AES).
- DES Data Encryption Standard
- 3-DES Triple Data Encryption Standard
- AES Advanced Encryption Standard
- data can be unencrypted upon transmission to the mobile computing device 150 associated with the user.
- data can remain encrypted throughout transmission to a mobile computing device (associated with the user, not associated with the user) and unencrypted at another module of a processing subsystem 160 (e.g., unencrypted in the cloud), wherein information derived from analysis of the data can then be transmitted back to the mobile computing device associated with the user in a secure manner.
- a user can thus pair his/her microsensor patch 110 with a mobile computing device unassociated with the user for transmission of encrypted data, and then later receive personalized body information at his/her own mobile computing device 150 after processing in the cloud.
- the linking interface 136 is a wired connection, wherein the linking interface 136 includes a wired jack connector (e.g., a 1 ⁇ 8′′ headphone jack, a USB connection, a mini-USB connection, a lightning cable connection, etc.) such that the transmitting unit 130 can communicate with the mobile computing device 150 and/or an external element through a complementary jack of the mobile device and/or external element.
- the linking interface 136 that includes a wired jack, the linking interface is configured only to transmit output signals from the transmitting unit 130 /microsensor patch 110 .
- the linking interface 136 is configured to transmit data to and from at least one element of transmitting unit 130 /transdermal path no assembly and a mobile computing device 150 .
- the linking interface 136 can transmit output signals into the mobile computing device 150 through an input of the jack of the mobile computing device 150 and can retrieve data from an output of the jack of the mobile computing device 150 .
- the linking interface 136 can communicate with the mobile computing device 150 via inter-integrated circuit communication (I2C), one-wire, master-slave, or any other suitable communication protocol.
- I2C inter-integrated circuit communication
- the linking interface can transmit data in any other way and can include any other type of wired connection that supports data transfer between the transmitting unit 130 and/or microsensor patch 110 , and the mobile computing device 150 .
- the electronics subsystem 120 can include any other suitable module(s) and/or be configured in any other suitable manner.
- the electronics subsystem 120 can include or be in communication with an actuator configured to automatically perform an action (e.g., vibration, provision of a biasing force) that biases the microsensor into communication with interstitial fluid of the user, in response to detection of unsuitable impedance derived from comparison between an impedance signal and an impedance threshold condition.
- an actuator configured to automatically perform an action (e.g., vibration, provision of a biasing force) that biases the microsensor into communication with interstitial fluid of the user, in response to detection of unsuitable impedance derived from comparison between an impedance signal and an impedance threshold condition.
- the housing 190 supports the microsensor 116 and the electronics subsystem 120 , and functions to facilitate robust coupling of the microsensor patch 110 to the user in a manner that allows the user to wear the microsensor patch no for a sufficient period of time (e.g., one week, one month, etc.).
- the housing 190 can also function to protect elements of the microsensor patch no from physical damage over the lifetime usage of the microsensor patch 110 .
- at least one portion of the housing 190 is flexible to facilitate adhesion to the user and compliance with skin of the user as the user moves in his/her daily life; however, at least a portion of the housing 190 can alternatively be rigid in order to provide more robust protection against physical damage.
- the housing 190 can comprise a single unit that entirely houses the microsensor 116 and the electronics subsystem 120 .
- the housing 190 can be configured to couple to the user using any suitable coupling mechanism (e.g., adhesive coupling mechanism, strap-based coupling mechanism, etc.).
- the housing 190 can alternatively be modular and comprise a set of portions, each portion configured to enable coupling of the microsensor 116 to the user and/or to house elements of the electronics subsystem 120 . Modularity of the housing 190 can thus allow portions of the system 100 to be disposable and/or reusable.
- the housing can comprise a first housing portion 191 and a second housing portion 196 , wherein the first housing portion 191 is configured to facilitate coupling of filaments of the microsensor 116 to the user, and the second housing portion 196 is configured to house elements of the electronics subsystem 120 and to couple the electronics subsystem 120 to the microsensor 116 by way of the first housing portion 191 .
- first housing portion 191 and the second housing portion 196 of this variation are preferably configured to mate with each other in a complementary manner (e.g., with a male-female coupling mechanism, with a magnetic coupling mechanism, with a latch-based coupling mechanism, with a lock-and-key based coupling mechanism, etc.).
- a complementary manner e.g., with a male-female coupling mechanism, with a magnetic coupling mechanism, with a latch-based coupling mechanism, with a lock-and-key based coupling mechanism, etc.
- the first housing portion 191 ′ includes an opening 192 ′, and a second housing portion 196 ′ is insertable into the opening of the first housing portion in a first configuration, wherein coupling between the first housing portion 191 ′ and the second housing portion 196 ′ provides a hermetic seal between the first housing portion 191 and the second housing portion 196 .
- FIG. 10A-10B the first housing portion 191 ′ includes an opening 192 ′, and a second housing portion 196 ′ is insertable into the opening of the first housing portion in a first configuration, wherein coupling between the first housing portion 191 ′ and the second housing portion 196 ′ provides a hermetic seal between the first housing portion 191 and the second housing portion 196 .
- the first housing portion 191 can include an o-ring 193 (e.g., an o-ring molded onto the material of the first housing portion) at a perimeter of the opening 192 , and a perimeter region of the second housing portion 196 can include a recessed region 197 that interfaces with the o-ring 193 in a manner that provides a hermetic seal.
- the opening 192 and the second housing portion 196 each have substantially circular footprints; however, the opening 192 and the second housing portion 196 can additionally or alternatively have any other suitable footprints or be configured in any other suitable manner.
- the first housing portion 191 ′ can comprise an adhesive substrate 91 having a microsensor opening 92 , a microsensor interface substrate 93 superior to the adhesive substrate and configured to pass the microsensor 92 through the microsensor opening 92 , a coupling ring 94 configured to retain the position of the microsensor interface substrate 93 relative to the adhesive substrate 91 and to provide an interface for mating with the second housing portion 196 , and a flexible cover 95 ensheathing the coupling ring 94 , coupled to the adhesive substrate 91 , and configured to maintain coupling between the adhesive substrate 191 , the microsensor interface substrate 93 , and the coupling ring 94 .
- the second housing portion 196 of the specific example is rigid, and configured to form a shell about the electronics subsystem 120 , while including openings that provide access for a set of contacts 98 that interface the electronics subsystem 120 with the microsensor interface substrate 93 when the first housing portion 191 is coupled to the second housing portion 196 .
- the microsensor interface substrate 93 of the specific example can include a circular printed circuit board comprising a set of concentric ring contacts 97 , as shown in FIG.
- the set of contacts 98 e.g., digital contacts
- orientation-unspecific coupling between the first housing portion 191 and the second housing portion 196 can be achieved in any other suitable manner.
- the first housing portion 191 and the second housing portion 196 can be configured to couple with a set orientation in order to ensure proper communication between the microsensor 116 and the electronics subsystem 120 .
- the first housing portion 191 and the second housing portion 196 can be coupled together and/or coupled to the user by way of a patch applicator 180 , as described in further detail below.
- a patch applicator 180 can be coupled together and/or coupled to the user by way of a patch applicator 180 , as described in further detail below.
- other variations of modularity can comprise any other suitable distribution of the microsensor 116 and elements of the electronics subsystem 120 across portions of the housing in any other suitable manner.
- the processing subsystem 16 o is in communication with the electronics subsystem 120 and functions to generate analyses pertaining to the user's body chemistry, and to transmit information derived from the analyses to the user at an electronic device associated with the user.
- the processing subsystem 160 can be implemented in one or more of: a computer machine, a remote server, a cloud computing system, a microprocessor, processing hardware of a mobile computing device (e.g., smartphone, tablet, head-mounted mobile computing device, wrist-borne mobile computing device, etc.) and any other suitable processing system.
- the software module can analyze an output provided by the transmitting unit 130 based on a set of parameters for multiple analytes characterizing a user's body chemistry, at a set of time points, and determine at least one metric based on the set of parameters at the set of time points.
- the software module can then determine and output at least one of a temporal trend in a metric, a temporal trend in an analyte parameter, absolute values of a metric, changes in value of a metric, absolute values of an analyte parameter, and changes in value of an analyte parameter.
- the software module 163 in this example can further be configured to communicate a suggestion to the user based on an analysis determined from the set of parameters for multiple analytes.
- the software module can be able to correlate at least one analyte parameter or metric to a user activity, such that the user is provided with information relating a value of the analyte parameter and/or metric to an activity that he or she has performed.
- the software module can additionally or alternatively provide an analysis that includes any other health- and/or user-related information that can be useful in treating, maintaining, and/or improving a health condition of a user.
- the software module can be implemented, at least in part, as an application executable on a mobile computing device 150 .
- the mobile computing device 150 is preferably a smartphone but can also be a tablet, laptop computer, PDA, e-book reader, head-mounted computing device, smart-watch, or any other mobile device.
- the software module can alternatively be an application executable on a desktop computer or web browser.
- the software module preferably includes an interface that accepts inputs from the user (e.g., user health condition, user characteristics, user activity), and uses these inputs in analyzing an output provided by the transmitting unit 130 .
- the software module also includes an interface that renders an analysis based on sensed analytes and/or user inputs in some form.
- the software module includes an interface that summarizes analyte parameter values in some manner (e.g., raw values, ranges, categories, changes), provides a trend (e.g., graph) in at least one analyte parameter or body chemistry metric, provides alerts or notifications, provides additional health metrics, and provides recommendations to modify or improve body chemistry and health metrics.
- the software module can implement two interfaces: a first interface accessible by a user, and a second interface accessible by a health care professional servicing the user.
- the software module 163 can additionally or alternatively execute fully or in part on a remote server.
- the software module can be a cloud-computing-based application that performs data analysis, calculations, and other actions remotely from the mobile computing device 150 .
- the mobile computing device 150 can receive an output of the transmitting unit 130 via the linking interface 136 and then transfer the output to the remote server upon which the software module executes.
- signals are preferably transferred via a wireless connection, such as a Bluetooth connection, 3G or 4G cellular connection, and/or via a Wi-Fi internet connection.
- a mobile computing device 150 can function to transmit data to and/or receive data from the software module.
- the software module 163 can further be integrated with a notification module 165 configured to provide an alert or notification to a user and/or health care professional based on the analysis of the output.
- the notification module 165 functions to access an analysis provided by the software module and to control transmission of a notification 166 to at least one of a user and a healthcare profession interacting with the user.
- the notification module 165 receives an analysis of the software module being executed on a mobile computing device 150 , and generates a notification 166 based upon the analysis.
- the notification 166 preferably contains information relevant to a body chemistry status of the user.
- the notification 166 can additionally include an explicit directive for the user to perform a certain action (e.g., eat, rest, or exercise) that affects the body chemistry of the user. Therefore, the notification 166 preferably systematically and repeatedly analyzes a body chemistry status of the user based on at least one analyte parameter of the user and provides and alert and/or advice to manage and monitor a user's body chemistry substantially in real time.
- the notification 166 can further include information related to what or how much to eat, where and how long to run, level of exertion, and/or how to rest and for how long in order to appropriately adjust body chemistry.
- the notification 166 can include any appropriate information relevant to monitoring a body chemistry metric of the user.
- the notification 166 can include a graphical rendering that shows analyte data from past to present using a line graph representation, wherein an amount (e.g., concentration) of the analyte is represented along a first axis and time is represented along a second axis.
- the graphical rendering can further include a “predicted region” based upon the analysis of the processing subsystem 160 , wherein the predicted region 66 depicts a prediction of where the analyte level will be at a future time point, and a width of the predicted region 66 indicates confidence in the prediction.
- the processing subsystem 160 can be coupled to or comprise a data storage unit 170 , as shown in FIG. 13 .
- the data storage unit 170 functions to retains data, such as an analysis provided by a software module, a notification 166 , and/or any other output of any element of the system 100 .
- the data storage unit 170 can be implemented with the microsensor patch 110 , transmitting unit 130 , mobile computing device 150 , personal computer, web browser, external server (e.g., cloud), and/or local server, or any combination of the above, in a network configured to transmit, store, and receive data.
- the patch applicator 180 ′ can be incorporated into a first housing portion 191 of a housing 190 of the system 100 and can comprise an elastic pin 181 (e.g., spring-loaded pin) configured to complement a recess of a second housing portion 196 .
- an elastic pin 181 e.g., spring-loaded pin
- a normal force applied to a broad surface of the second housing portion 196 initially causes the elastic pin 181 to retract, and rebounding of the elastic pin 181 into the recess of the second housing portion 196 biases and accelerates the microsensor 116 into the skin of the user.
- the patch applicator 180 ′′ implements elastic portions of the housing 190 , which can be used to retract a housing portion with the microsensor 116 and to release the housing portion, thereby accelerating the microsensor 116 into skin of the user.
- the patch applicator cooperates with a first housing portion 191 and a second housing portion 196 , wherein the patch applicator comprises a first applicator portion configured to surround the housing 190 and interface with the second housing portion 196 , and a second applicator portion configured to accelerate the second housing portion toward skin of the user.
- the patch applicator 180 a comprises a ram-and-catch mechanism, wherein twisting of a rotatable component 83 of the patch applicator 180 a transitions a plunger 84 of the patch applicator 180 a from a resting configuration 84 a to a loaded configuration 84 b , as shown in FIGS.
- twisting of the rotatable component 83 transitions the plunger 84 along ramped surfaces 85 of the patch applicator 180 a to the loaded configuration 84 a , where the plunger 84 rests on triggers 86 of the patch applicator 180 a . Then, as shown in FIG.
- the translating component 88 is biased in holding position 188 a , and pushing of the translating component 88 places a lateral biasing force on the trigger 188 against the biasing spring 189 (e.g., due to wedge-shaped morphology of the trigger 188 that interacts with a complementary portion of the translating component 88 ), thereby releasing the plunger 84 ′ to accelerate the microsensor 116 toward skin of the user.
- compression of the elastic component 89 creates a reverse biasing force that automatically releases the translating component 88 toward the resting configuration 88 a.
- the system can include a base station 5 that functions to receive the microsensor patch 110 (e.g., within a second housing portion 196 ).
- the base station 5 can include alignment elements 6 (e.g., protrusions, recesses, magnetic alignment elements, etc.) that facilitate alignment of the microsensor patch 110 within the base station, as shown in FIG. 18A .
- the base station 5 can additionally or alternatively facilitate charging of a rechargeable battery of the microsensor patch 110 by including elements that generate an electromagnetic field that interacts with a charging coil coupled to the battery, thereby charging the battery 138 .
- the base station 5 can additionally or alternatively be used to transition the microsensor patch between different operational states, in relation to data transfer between the microsensor patch 110 , a mobile computing device 150 associated with the user, and modules of a processing subsystem 160 (e.g., cloud module) as shown in FIG. 19 .
- a processing subsystem 160 e.g., cloud module
- the transmitting unit 130 of the microsensor patch 110 and the mobile computing device 150 can pair/bond only when the second housing portion 196 of the microsensor patch 110 is in communication with the base station 5 (e.g., aligned within the base station 5 ).
- the microsensor patch 110 can transmit and receive data (e.g., compact raw data compounded into a plurality of bits over Bluetooth communication).
- the microsensor patch 110 can be configured to only transmit data (but not receive data), thereby reducing energy usage, preventing man-in-the-middle attack, and preventing tampering. As such, the second operation mode 5 b prevents reading of data from the microsensor patch 110 by a fraudulent entity, without gaining physical access to the microsensor patch 110 .
- the operation modes of the system 100 enabled by the microsensor patch, the base station 5 , the mobile computing device 150 , and the processing subsystem 160 are further detailed in FIG. 19 .
- the mobile computing device 150 functions to provide one or more of: data relay, data visualization, data storage, notification, and action functions (e.g., as described in relation to the software module 163 described above).
- the mobile computing device 150 can be configured to transmit raw data in Javascript Object Notation (JSON) format (or any other suitable format) to be processed in the cloud, and analyte data, notifications, and alerts (e.g., as derived from an analysis) can be transmitted back to the mobile computing device 150 in JSON format (or any other suitable format).
- JSON Javascript Object Notation
- the cloud module of the processing subsystem 160 can thus serve to enable authentication of the user (e.g., in association with a user account of a native application) and/or data, data storage, data processing, notification, and prediction functions, as described in relation to the processing subsystem 160 described above.
- the system 100 is configured for fault tolerance, wherein the microsensor patch 110 stores data when faulty operation of the mobile computing device 150 occurs, and failure of the processing subsystem 100 results in data storage at the mobile computing device.
- the system 100 can, however, be configured in any other suitable manner.
- the base station 5 and the patch applicator 180 can be configured to couple together, thus facilitating portability of the base station 5 and patch applicator 180 .
- the base station 5 , patch applicator 180 , and microsensor no can alternatively be configured to couple or not couple together in any other suitable manner.
- the microsensor patch 110 is preferably calibrated to prevent signal degradation and to mitigate the effects of transient effects experienced during analyte sensing.
- the primary sensing mechanism is potentiometric for small analytes (e.g., potassium, sodium, calcium), and amperometric for large molecules (e.g., glucose, lactic, creatinine).
- the microsensor patch no passively detects analytes by detecting an impedance and/or capacitance change, as well as a voltage change when an analyte or analyte concentration contacts the microsensor 116 . Calibration can occur by normalizing sensing measurements relative to a grounded portion of the microsensor 116 , such as a reference electrode.
- the microsensor patch no can employ injection of a volume of a calibration solution with a known concentration of at least one analyte, in order to calibrate the microsensor patch 110 .
- the calibration solution can have a known concentration of at least one analyte, such that changes (e.g., changes in electrical parameters) detected by the microsensor patch no in response to the calibration solution can be used to normalize measurements resulting from sensed analytes or analyte concentrations occurring after injection of the volume of calibration solution.
- the calibration solution can be injected automatically and periodically over the lifetime usage of the transdermal patch; however, the calibration solution can alternatively be injected when prompted by a user or other entity.
- the microsensor patch no can include a coating or a cap comprising a soluble species (e.g., analyte/ion) with a well-known solubility, in order to calibrate the microsensor patch no.
- a soluble species e.g., analyte/ion
- the soluble species maintains a known concentration of the species within the vicinity of a filament that can be used to normalize and/or calibrate a signal.
- soluble species include low solubility, biocompatible calcium salts, such as calcium carbonate, calcium phosphate, and dicalcium phosphate for calcium sensing. Other suitable soluble species can be used to calibrate other analytes.
- the microsensor patch 110 can use any other suitable calibration method.
- the transdermal patch can be pre-staged, prepped, loaded, or activated to have a set calibration state enabling calibration of the system after application to the user within a desired period of time (e.g., an 85 mg/dl calibration state equilibrated after insertion within a period of 2 hours).
- a method 200 for monitoring body chemistry of a user comprises: receiving a second housing portion into an opening of a first housing portion S 210 , the first housing portion supporting a microsensor including a first working electrode, a second working electrode, a reference electrode, and a counter electrode, and the second housing portion supporting an electronics subsystem configured to receive a signal stream from the microsensor; after interfacing with the second housing portion, accelerating the second housing portion toward skin of the user S 220 , thereby delivering sensing regions of the microsensor into interstitial fluid of the user; generating an impedance signal, from two of the first working electrode, the second working electrode, the reference electrode, and the counter electrode, in response to applying a voltage, near a shifted potential different than a reference potential of the reference electrode S 230 , wherein the shifted potential is associated with a signal conditioning module of the electronics subsystem; at a processing system in communication with the electronics subsystem, receiving the signal stream and the impedance signal S 240 ; at the processing system,
- each block in the flowchart or block diagrams may represent a module, segment, step, or portion of code, which comprises one or more executable instructions for implementing the specified logical function(s).
- the functions noted in the block can occur out of the order noted in the FIGURES. For example, two blocks shown in succession may, in fact, be executed substantially concurrently, or the blocks may sometimes be executed in the reverse order, depending upon the functionality involved.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Physiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Signal Processing (AREA)
- Psychiatry (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Business, Economics & Management (AREA)
- Radiology & Medical Imaging (AREA)
- Computer Security & Cryptography (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Bioethics (AREA)
- Accounting & Taxation (AREA)
- Development Economics (AREA)
- Economics (AREA)
- Computing Systems (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 14/657,973, filed 13 Mar. 2015, which claims the benefit of U.S. Provisional Application Ser. No. 61/952,594, filed on 13 Mar. 2014, U.S. Provisional Application Ser. No. 62/012,874, filed on 16 Jun. 2014, and U.S. Provisional Application Ser. No. 62/025,174, filed on 16 Jul. 2014, which are each incorporated herein in its entirety by this reference.
- This invention relates generally to the biometric device field, and more specifically to a new and useful system for monitoring body chemistry in the biometric device field.
- Biomonitoring devices are commonly used, particularly by health-conscious individuals and individuals diagnosed with ailments, to monitor body chemistry. Such biomonitoring devices perform the tasks of determining an analyte level in a user's body, and providing information regarding the analyte level to a user; however, these current biomonitoring devices typically convey information to users that is limited in detail, intermittent, and prompted by the command of the user. Such biomonitoring devices, including blood glucose meters, are also inappropriate for many applications outside of intermittent use, and place significant burdens on users (e.g., in requiring finger sticks, in requiring lancing, etc.) due to design and manufacture considerations. Additionally, current devices are configured to analyze one or a limited number of analytes contributing to overall body chemistry, due to limitations of sensors used in current biomonitoring devices.
- There is thus a need in the biometric device field to create a new and useful system for monitoring body chemistry. This invention provides such a new and useful system.
-
FIG. 1 depicts elements of an embodiment of a system for monitoring body chemistry; -
FIGS. 2A and 2B depict embodiments of a microsensor patch, a transmitting unit, a housing, and an array of filaments in an embodiment of a system for monitoring body chemistry; -
FIG. 2C depict a variation of electrodes in an embodiment of a system for monitoring body chemistry; -
FIGS. 3A-3H depict examples of filament variations in an embodiment of a system for monitoring body chemistry; -
FIG. 4 depicts an embodiment of an electronics subsystem in an embodiment of a system for monitoring body chemistry; -
FIGS. 5A-5C depict examples of a portion of an electronics subsystem in an embodiment of a system for monitoring body chemistry; -
FIGS. 6A-6B depict examples of power management modules in an embodiment of a system for monitoring body chemistry; -
FIG. 7 depicts a variation of an impedance detection module in an embodiment of a system for monitoring body chemistry; -
FIG. 8 depicts an example of an applied voltage waveform in an embodiment of a system for monitoring body chemistry; -
FIG. 9 depicts a variation of a housing in an embodiment of a system for monitoring body chemistry; -
FIGS. 10A-10B depict specific examples of a housing in an embodiment of a system for monitoring body chemistry; -
FIG. 10C depicts a specific portion of a housing in an embodiment of a system for monitoring body chemistry; -
FIGS. 11A-11B depict examples of user interfaces implemented using a software module in an embodiment of a system for monitoring body chemistry; -
FIG. 12A depicts a notification module of an embodiment of a system for monitoring body chemistry; -
FIGS. 12B-12C depict specific examples of notifications in an embodiment of a system for monitoring body chemistry; -
FIG. 13 depicts communication between a processing subsystem and a storage module in an embodiment of a system for monitoring body chemistry; -
FIGS. 14A-14C depict examples of an arch application method and an end-to-end application method, respectively, in an embodiment of a system for monitoring body chemistry; -
FIGS. 15A-15B depict variations of a patch applicator in an embodiment of a system for monitoring body chemistry; -
FIGS. 16A-16D depict a first specific example of a patch applicator in an embodiment of a system for monitoring body chemistry; -
FIG. 17 depicts a second specific example of a patch applicator in an embodiment of a system for monitoring body chemistry; -
FIGS. 18A-18B depict a specific example of a base station in an embodiment of a system for monitoring body chemistry; -
FIG. 19 depicts operation modes of components of an embodiment of a system for monitoring body chemistry; and -
FIG. 20 depicts an embodiment of a method for monitoring body chemistry. - The following description of the preferred embodiments of the invention is not intended to limit the invention to these preferred embodiments, but rather to enable any person skilled in the art to make and use this invention.
- As shown in
FIG. 1 , an embodiment of thesystem 100 for monitoring body chemistry of a user comprises ahousing 190 that supports amicrosensor 116 and anelectronics subsystem 120 in communication with themicrosensor 116; and aprocessing subsystem 160 configured to generate an analysis indicative of an analyte parameter of the user, wherein the analysis is derived from a signal stream of the microsensor and an impedance signal from the electronics subsystem. In more detail, thehousing 190,microsensor 116, and theelectronics subsystem 120 can be configured as amicrosensor patch 110 configured to sense analyte levels in a user's body, wherein the electronics subsystem includes asignal conditioning module 122, apower management module 124, astorage module 127, and a transmittingunit 130 in communication with theprocessing subsystem 160 and/or an electronic device (e.g., mobile computing device iso) associated with the user. - In some variations, the
system 100 can further include apatch applicator 180 configured to facilitate application of themicrosensor patch 110 onto the body of a user in a reliable manner. Thesystem 100 functions to provide continuous monitoring of a user's body chemistry through reception and processing of signals associated with one or more analytes present in the body of the user, and to provide an analysis of the user's body chemistry to the user and/or an entity (e.g., health care professional, caretaker, relative, friend, acquaintance, etc.) associated with the user. Alternatively, thesystem 100 can function to detect a user's body chemistry upon the user's request or sporadically, and/or can provide an analysis of the user's body chemistry only to the user. - The
system 100 is configured to be worn by the patient outside of a clinical (e.g., hospital) or research (e.g., laboratory) setting, such that the patient can be in a non-contrived environment as he or she is interfacing with themicrosensor patch 110 for monitoring of body chemistry. Furthermore, elements of thesystem 100 can be reusable or disposable (e.g., based upon modularity of the system 100), or theentire system 100 can be configured to be disposable. In one specific example, thesystem 100 adheres to the patient (thus not compelling the patient to hold any part of thesystem 100 by hand), has a low profile that conforms to the patient, and is configured to receive and transmit signals indicative of body chemistry parameters of the user, for downstream analysis and information transfer to the user. Alternatively, thesystem 100 can be substantially non-portable, non-wearable, and/or intended for use in a clinical or research setting. - As indicated above and further below, elements of the system can be implemented on one or more computer networks, computer systems, or applications servers, etc. The computer system(s) can comprise one or more of: a cloud-based computer, a mainframe computer system, a grid-computer system, or any other suitable computer system, and the computer system can support collection of data from a wearable device and/or a base station, processing of these data, and transmission of alerts, notifications, and/or user interface updates to one or more electronic computing devices (e.g., mobile computing device, wrist-borne mobile computing device, head-mounted mobile computing device, etc.) linked to or affiliated with an account of the user. For example, the computer system can receive signals indicative of one or more analyte parameters of the user and distribute alerts and notifications over a distributed network, such as over a cellular network or over an Internet connection. In this example, the computer system can upload alerts and notifications to a native body chemistry monitoring application including the user interface and executing on a mobile computing device associated with the user.
- Additionally or alternatively, an electronic computing device (e.g., a laptop computer, a desktop computer, a tablet, a smartphone, a smart watch, a smart eyewear accessory, a personal data assistant, etc.) associated with the system (e.g., with the account of the user) can maintain the account of the user, create and maintain a user-specific model within the account, and execute a native body chemistry monitoring application (including the user interface) with functions including one or more of: generating alerts or notifications, receiving alerts or notifications, displaying alerts or notifications, updating predictions of changes in state of the user, and any other suitable function that enhances body chemistry monitoring of the user. The
system 100 is preferably configured to implement at least a portion of themethod 200 described inSection 2 below; however, thesystem 100 can additionally or alternatively be configured to implement any other suitable method. - As shown in
FIG. 1 , themicrosensor patch 110 comprises amicrosensor 116 and anelectronics subsystem 120 in communication with themicrosensor 116, wherein themicrosensor 116 and theelectronics subsystem 120 are supported by ahousing 190. Themicrosensor patch 110 can be configured to detect and sense only a single analyte; however, the microsensor patch no can alternatively be configured to detect and sense multiple analytes in order to provide an analysis based on multiple analytes. Preferably, the microsensor patch no is configured to be disposable; however, the microsensor patch no can alternatively be configured to be reusable for any suitable duration or number of uses. In one variation, themicrosensor patch 110 is configured to be a semi-permanent component (e.g., wearable for a week before replacement, wearable for a month before replacement, etc.) configured to sense the user's body chemistry with minimal signal degradation for at a least a week post-coupling of the microsensor patch no to the body of the user. However, in another variation, themicrosensor patch 110 can be configured to be a permanent component configured to permanently couple to a user. Modularity of themicrosensor patch 110 is described in further detail below. - The
microsensor 116 of the microsensor patch no preferably comprises an array offilaments 117, as shown inFIGS. 1 and 2A , and functions to penetrate skin of the user in order to sense one or more analytes characterizing the user's body chemistry. Preferably, the array offilaments 117 is configured to penetrate the user's stratum corneum (i.e., an outer skin layer) in order to sense analytes within interstitial (extracellular) fluid, which is throughout the body; however, the array offilaments 117 can be configured to penetrate the user's skin to any other suitable depth. For instance, themicrosensor 116 can alternatively be configured to penetrate deeper layers, or various depth layers of a user's skin in order to sense analytes within any appropriate bodily fluid of the user. Themicrosensor 116 can be configured to sense analytes/ions characterizing a user's body chemistry using a potentiometric measurement (e.g., for small analytes including potassium, sodium calcium, etc.), using an amperometric measurement (e.g., for large analytes including glucose, lactic acid, creatinine, etc.), using a conductometric measurement, and/or using any other suitable measurement. - Preferably, sensed analytes result in a signal (e.g., voltage, current, resistance, capacitance, impedance, gravimetric, etc.) detectable by the
electronics subsystem 120 in communication with themicrosensor 116; however, analyte sensing can comprise any other appropriate mechanism using themicrosensor 116. As mentioned earlier, themicrosensor 116 is also preferably integrated with theelectronics subsystem 120. In a first variation, themicrosensor 116 is coupled to the semiconductor architecture of the electronics subsystem 120 (e.g., themicrosensor 116 is coupled to an integrated circuit comprising the electronics subsystem 120), in a second variation, themicrosensor 116 is more closely integrated into the semiconductor architecture of the electronics subsystem 120 (e.g., there is closer integration between the microsensor 116 and an integrated circuit including the electronics subsystem 120), and in a third variation, themicrosensor 116 and theelectronics subsystem 120 are constructed in a system-on-a-chip fashion (e.g., all components are integrated into a single chip). As such, in some variations, filaments the array offilaments 117 of themicrosensor 116 can be directly or indirectly integrated with electronics components, such that preprocessing of a signal from themicrosensor 116 can be performed using the electronics components (e.g., of the array offilaments 117, of the electronics subsystem 120) prior to or after transmitting signals to the electronics subsystem 120 (e.g., to an analog front end, to an analog to digital converter). The electronics components can be coupled to a filament substrate, or otherwise integrated with the filaments in any suitable fashion (e.g., wired, using a contact pad, etc.). Alternatively, the electronics components can be fully integrated into theelectronics subsystem 120 and configured to communicate with themicrosensor 116, or the electronics components can be split between the microsensor and theelectronics subsystem 120. Themicrosensor 116 can, however, comprise any other suitable architecture or configuration. - The
microsensor 116 preferably senses analyte parameters using the array offilaments 117, such that absolute values of specific analytes/ions can be detected and analyzed. Themicrosensor 116 can additionally be configured to sense analyte parameters using the array offilaments 117, such that changes in values of specific analyte/ion parameters or derivatives thereof (e.g., trends in values of a parameter, slopes of curves characterizing a trend in a parameter vs. another parameter, areas under curves characterizing a trend, a duration of time spent within a certain parameter range, etc.) can be detected and analyzed. In one variation, sensing by themicrosensor 116 is achieved at a low frequency at discrete time points (e.g., every minute, or every hour), and in another variation, sensing by themicrosensor 116 is achieved substantially continuously at a high frequency (e.g., every picosecond, every millisecond, every second). In one specific example for blood chemistry analysis, the array offilaments 117 of themicrosensor 116 is configured to sense one or more of: electrolytes, glucose, bicarbonate, creatinine, body urea nitrogen (BUN), sodium, iodide, iodine and potassium of a user's blood chemistry. In another specific example, the array offilaments 117 of themicrosensor 116 is configured to sense at least one of biomarkers, cell count, hormone levels, alcohol content, gases (e.g. carbon dioxide, oxygen, etc.), drug concentrations/metabolism, pH and analytes within a user's body fluid. - As shown in
FIG. 2A , the array offilaments 117 is preferably located at the base surface of themicrosensor patch 110, and functions to interface directly with a user in a transdermal manner (e.g., in accessing interstitial fluid) in order to sense at least one analyte/ion characterizing the user's body chemistry. The array offilaments 117 is preferably arranged in a uniform pattern with a specified density optimized to effectively penetrate a user's skin and provide an appropriate signal, while minimizing pain to the user. Additionally, the array offilaments 117 can be arranged in a manner to optimize coupling to the user, such that the microsensor firmly couples to the user over the lifetime usage of the system. For example, thefilaments 118 can comprise several pieces and/or be attached to a flexible base to allow the array offilaments 117 to conform to a user's body. In one variation, the array offilaments 117 is arranged in a rectangular pattern, and in another variation, the array offilaments 117 is arranged in a circular or ellipsoid pattern. However, in other variations, the array offilaments 117 can be arranged in any other suitable manner (e.g., a random arrangement). The array offilaments 117 can also be configured to facilitate coupling to a user, by comprising filaments of different lengths or geometries. Havingfilaments 118 of different lengths can further function to allow measurement of different ions/analytes at different depths of penetration (e.g., a filament with a first length can sense one analyte at a first depth, and a filament with a second length can sense another analyte at a second depth). The array offilaments 117 can also comprisefilaments 118 of different geometries (e.g., height, diameter) to facilitate sensing of analytes/ions at lower or higher concentrations. In one specific example, the array offilaments 117 is arranged at a density of 100 filaments per square centimeter and eachfilament 118 in the array offilaments 117 has a length of 250-350 microns, which allows appropriate levels of detection, coupling to a user, and pain experienced by the user. - Each
filament 118 in the array offilaments 117 preferably functions to sense a single analyte; however, eachfilament 118 in the array offilaments 117 can additionally be configured to sense more than one analyte. Furthermore, the array offilaments 117 can be further configured, such that a subarray of the array offilaments 117 functions as a single sensor configured to sense a particular analyte or biomarker, as shown inFIG. 2B . Furthermore, any configuration of subarrays of the array offilaments 117 can additionally or alternatively be configured as one or more of: a working electrode, a counter electrode (i.e., auxiliary electrode), and a reference electrode, for instance, in a two-electrode cell, a three-electrode cell, or a more-than-three-electrode cell. In one variation, as shown inFIG. 2C , the array offilaments 117 of themicrosensor 116 is configured as a first working electrode 11 (corresponding to a first subarray of filaments), a second working electrode 12 (corresponding to a second subarray of filaments), a counter electrode 13 (corresponding to a third subarray of filaments), and a reference electrode 14 (corresponding to a fourth subarray of filaments). In a specific example of this variation, each subarray associated with the first workingelectrode 11, the second workingelectrode 12, thecounter electrode 13, and thereference electrode 14, respectively, is substantially identical in morphology (e.g., area of the microsensor). Furthermore, in the specific example, each subarray has a square footprint, and the subarrays are configured in a 2×2 arrangement to define a larger square footprint. However, the array offilaments 117 can be configured as one or more of: a working electrode, a counter electrode, and a reference electrode in any other suitable manner, and can furthermore have any other suitable morphology(ies) and/or configuration relative to each other. - Additionally or alternatively, any subarray of the array of
filaments 117 can be configured to release biomaterials (e.g., therapeutic substances, drugs) for treating a medical condition of a user (e.g., as facilitated by biomaterial dissolution in interstitial fluid). Multiple subarrays of the array of filaments can then be configured to sense different analytes/biomarkers, or the same analyte/biomarker. Furthermore, a subarray or asingle filament 118 of the array offilaments 117 can be configured as a ground region of themicrosensor 116, such that signals generated by themicrosensor 116 in response to analyte detection can be normalized by the signals generated by the subarray orsingle filament 118 serving as a ground region. Preferably, all subarrays of the array offilaments 117 are substantially equal in size and density; however, each subarray of the array offilaments 117 can alternatively be optimized to maximize signal generation and detection in response to a specific analyte. In an example, analytes that are known to have a lower concentration within a user's body fluid can correspond to a larger subarray of the array offilaments 117. In another example, analytes that are known to have a higher concentration within a user's body fluid can correspond to a smaller subarray of the array offilaments 117. In one extreme example, an entire array of filaments can be configured to sense a single analyte, such that themicrosensor 116 andmicrosensor patch 110 is configured to sense and detect only one analyte. In another extreme example, each single filament in an array can be configured to detect a single analyte allowing for detection of multiple analytes within a single array (e.g., for a 100-filament array, 100 analytes can be tested). - In other variations, a subarray of the array of
filaments 117 can also be used to detect other physiologically relevant parameters, such as electrophysiological signals (e.g., electrocardiogram, electroencephalogram), body temperature, respiration, and skin impedance change (e.g., to measure hydration state or inflammatory response). In these other variations, the subarray can be dedicated to measuring these physiologically relevant parameters, which could be combined with analyte/ion parameter measurements in order to provide meaningful information to a user. As an example, the simultaneous measurement of potassium levels and electrocardiogram measurements, enabled by subarrays of the array offilaments 117, can provide a more complete diagnosis of cardiovascular problems or events than either measurement by itself. - A filament 118 of the array of filaments can comprise one or more of: a substrate core, the substrate core including a base end coupled to the substrate, a columnar protrusion having a proximal portion coupled to the base end and a distal portion, and a tip region coupled to the distal portion of the columnar protrusion and that facilitates access to the body fluid of the user; a conductive layer, isolated to the tip region of the substrate core and isolated away from the base end and the columnar protrusion as an active region that enables transmission of electronic signals generated upon detection of an analyte; an insulating layer ensheathing the columnar protrusion and base end of the substrate core and exposing a portion of the conductive layer, thereby defining a boundary of the active region; a sensing layer, in communication with the active region, characterized by reversible redox behavior for transduction of an ionic concentration of the analyte into an electronic signal; an intermediate selective layer superficial to the conductive layer and deeper than the sensing layer, relative to a most distal point of the tip region of the filament, that facilitates detection of the analyte; an intermediate protective layer, superficial to the intermediate selective layer, including a functional compound that promotes generation of a protective barrier; and a selective coating superficial to the intermediate protective layer, having a distribution of molecules that respond to presence of the analyte, superficial to the sensing layer. Thus, a filament can comprise one or more regions, morphologies (examples of which are shown in
FIGS. 3A-3H , withelements 118 a-118 h), compositions, and/or configurations as described in U.S. Pub. No. 2014/0275897, entitled “On-Body Microsensor for Biomonitoring” and filed on 14 Mar. 2014 and/or U.S. App. No. 62/025,174, and entitled “System for Monitoring Body Chemistry” and filed on 16 Jul. 2014, which are each incorporated herein in their entirety by this reference. However, the filament can additionally or alternatively comprise any other suitable region, composition, morphology, and/or configuration. - The electronics subsystem 120 functions to receive analog signals from the
microsensor 116 and to convert them into digital signals to be processed by amicroprocessor 113 of theelectronics subsystem 120. In receiving signals, processing signals, regulating function, storing data, and/or transmitting data, theelectronics subsystem 120 preferably includes amicroprocessor 113 interfacing with one or more of: asignal conditioning module 122, apower management module 124, animpedance detection module 126, astorage module 127, and a transmittingunit 130, as shown inFIG. 4 . However, theelectronics subsystem 120 can additionally or alternatively include any other suitable modules configured to facilitate signal reception, signal processing, and data transfer in an efficient manner. - The
microprocessor 113 preferably includes memory and/or is coupled to a storage module 127 (e.g., flash storage). Themicroprocessor 113 can also include and/or be coupled to a clock/watchdog module (which can be incorporated into a microcontroller unit) for control of timing between different functions of theelectronics subsystem 120. Themicroprocessor 113 functions to process received signals, enable power distribution, enable impedance monitoring, and enable data transmission from theelectronics subsystem 120, in relation to other portions of theelectronics subsystem 120 described below; however, themicroprocessor 113 can alternatively or additionally be configured to perform any other suitable function. - The
signal conditioning module 122 functions to preprocess signals detected and received using themicrosensor 116, thereby producing conditioned data prior to processing at theprocessing subsystem 160. Thesignal conditioning module 122 can include one or more of: a signal multiplexer, an analog front end, an amplifier (e.g., a variable gain amplifier), a filter (e.g., low pass filter, high pass filter, band pass filter, etc.), an analog-to-digital converter (ADC), and a digital-to-analog converter (DAC). In one variation, as shown inFIG. 4 , thesignal conditioning module 122 comprises amultiplexer 22 in communication with themicrosensor 116, wherein themultiplexer 22 is configured to communicate an output to an analogfront end 23 that interfaces themicrosensor 116 with anADC 24 by way of avariable gain amplifier 25 coupled to afilter 26. In a specific example of this variation, the analogfront end 23 circuitry is configured with a shifted potential different than a reference potential of thereference electrode 14 of themicrosensor 116, wherein the shifted potential is different (e.g., −2V to 2V different) from the reference potential of thereference electrode 14. The configuration involving a difference between the shifted potential and the reference potential can allow thesystem 100 to drive redox reactions at the surface of themicrosensor 110. However, in alternative variations of the specific example, the analog front end (or any other element of the signal conditioning module 122) can be configured with any other suitable potential relative to potentials of electrodes of themicrosensor 116. - In more detail, the
multiplexer 22 of thesignal conditioning module 122 is preferably configured to receive multiple signals from the microsensor 116 (e.g., from subarrays of the array of filaments 117) and to forward the multiple signals received at multiple input lines in a single line at the analog front end. Themultiplexer 22 thus increases an amount of data that can be transmitted within a given time constraint and/or bandwidth constraint. The number of input channels to themultiplexer 22 is preferably greater than or equal to the number of output channels of themicrosensor 116, and can have any suitable relationship between the number of input lines into themultiplexer 22, select lines of the multiplexer, and output lines from themultiplexer 22. In some variations, themultiplexer 22 can include a post-multiplexer gain in order to reduce capacitance values of the analogfront end 23 coupled to themultiplexer 22, and which can also be used to limit a number of amplifiers of theelectronics 120, such that a single amplifier is coupled to the multiplexer 22 (as opposed to amplifiers coupled to each individual sensor); however, themultiplexer 22 can alternatively not include any gain producing elements. In some variations, themultiplexer 22 can additionally or alternatively include high frequency and/or low frequency limiting elements. However, themultiplexer 22 can additionally or alternatively be configured in any other suitable manner. Furthermore, in alternative variations, thesignal conditioning module 122 can omit a multiplexer and/or comprise or omit any other suitable element. - In variations, an interface between the microsensor 116 and other elements of the
electronics subsystem 120 can be configured in a manner that prevents or otherwise reduces leakage current effects due to a redox potential of the microsensor 16 in relation to otherelements electronics subsystem 120. In a first configuration, a leakage current effect can result when a diode to ground (e.g., an ESD-diode to ground) is configured at an interface between the microsensor 116 and amultiplexer 22, as shown inFIG. 5A . To prevent or otherwise reduce the leakage current effect, a set ofdiodes 70, comprising a first diode 71 (e.g., a first EST-diode) and a second diode 72 (e.g., a second ESD-diode), configured at an interface between the microsensor 116 and themultiplexer 22 can be coupled to an element 73 (e.g., inductor, ferrite bead, resistor, etc.) that provides a high resistance to transient voltage spikes and directs any discharge through thesecond diode 72 to ground (instead of damaging the electronics subsystem 120), as shown inFIG. 5B . Themultiplexer 22 can also comprise aswitch 75, as shown inFIG. 5C , that allows altering of potentials within the analogfront end 23. As shown inFIG. 5C , eliminating a voltage difference (i.e., between Vs and V2) eliminates or otherwise reduces leakage currents that can affect readings from themicrosensor 110. - The
power management module 124 functions to provide dynamic modulation of power transfer to and from elements of themicrosensor patch 110, in a manner that enables efficient operation of thesystem 100. Preferably, thepower management module 124 interfaces with abattery 138 and elements of the transmittingunit 130 requiring power (e.g., by way of amicroprocessor 113, as shown inFIG. 4 ), as described in further detail below. Additionally, thepower management module 124 can further interface with an external processing element of theprocessing subsystem 160, such that thepower management module 124 can be at least partially implemented in firmware. In one such variation of thepower management module 124, wherein power management is achieved in firmware, thepower management module 124 can be configured to anticipate power requirements of one or more elements, and to automatically operate at the highest demanded power mode (e.g., voltage) required, while never dropping below a minimum power level required by the elements. Thepower management module 124 can also facilitate efficient switching of components to an “off” state when not needed, in order to contribute to lower current consumption. Additionally or alternatively, thepower management module 124 can be configured to dynamically trigger high current draw sensing components (e.g., the impedance detection module 126) to an “on” state, only when needed, by monitoring other system components (e.g., voltage of a counter electrode 13). - In an example, as shown in
FIG. 6A , a group of elements requiring different operating power levels can be coupled to thepower management module 124, and thepower management module 124 can output power at the highest operating power level anticipated among the elements. Disparate elements can also set a minimum level of power they require, and as elements vary their power requirements, thepower management module 124 can then automatically adjust power output such that a power level provided never drops below the lowest power level required. In this variation, elements of themicrosensor patch 110 requiring power are thus dynamically provided with their highest demanded power level, to substantially limit energy wasted by thesystem 100 and to satisfy power level requirements of all running elements. In another variation of thepower management module 124, wherein power management is achieved in firmware, thepower management module 124 can be configured to detect elements requiring power, and to automatically operate at the highest demanded power mode (e.g., voltage) required. In an example, a group of elements requiring different operating voltages can be detected, and thepower management module 124 can output power at the highest operating voltage detected. As elements vary their voltage requirements, thepower management module 124 can then automatically adjust voltage output to meet the highest demanded voltage. In this variation, elements of themicrosensor patch 110 requiring power are thus dynamically provided with their highest demanded voltage, to substantially limit energy wasted by thesystem 100. - In other variations, power management can be achieved by the
power management module 124 without implementation in firmware, such that power management occurs in circuitry. In these other variations, an example of which is shown inFIG. 6B , power management can comprise providing a set amount of power to elements requiring power, and completely eliminating power transfer to elements not requiring power. Thesystem 100 can, however, comprise any other suitable variation of thepower management modules 124. - In relation to the
power management module 124, theelectronics subsystem 120 can comprise abattery 138, which functions to serve as a power source for theelectronics subsystem 120. Thebattery 138 is preferably coupled to afuel gage 38 and a chargingdetection module 39, each of which is coupled to the microprocessor 113 (described in further detail below). Thebattery 138 is preferably a lithium-ion battery that is configured to be rechargeable, but can be any appropriate rechargeable battery (e.g., nickel-cadmium, nickel metal hydride, or lithium-ion polymer). Alternatively, thebattery 138 may not be a rechargeable battery. Preferably, thebattery 138 is configured to have a profile with a low aspect ratio, contributing to a thin form factor of themicrosensor patch 110. However, thebattery 138 can be configured to have any appropriate profile such that thebattery 130 provides adequate power characteristics (e.g., cycle life, charging time, discharge time, etc.) for thesystem 100. In some variations, a thin-film battery can be integrated with the microsensor patch no in order to facilitate substantially continuous analyte detection by thesystem 100, independent of themicroprocessor 113 and digital electronics of theelectronics subsystem 120. - In embodiments where the
battery 138 is rechargeable, theelectronics subsystem 120 can also comprise a chargingcoil 140 that functions to provide inductive charging for thebattery 138, and a chargingdetection module 39, in communication with themicroprocessor 113, that enable detection of charging of thebattery 138. The chargingcoil 140 is preferably coupled to thebattery 138 and converts energy from an electromagnetic field (e.g., provided by an element of a base station, as described in further detail below), into electrical energy to charge thebattery 138. Inductive charging provided by the chargingcoil 140 thus facilitates user mobility while interacting with thesystem 100. In alternative variations, however, the chargingcoil 140 can altogether be omitted (e.g., in embodiments without a rechargeable battery), or replaced by a connection configured to provide wired charging of a rechargeable battery. - Additionally or alternatively, in some variations, the
microsensor patch 110 can comprise a semi-active or fully-active power cell (e.g., implementing microelectromechanical system elements) that functions to absorb and/or release generated energy from any one or more of: body heat of the user, body movement of the user (e.g., with piezoelectric elements, with capacitive elements), static voltage from the environment of the user, light in the environment of the user (e.g., using solar cells), magnetic energy flux, galvanic differentials, and any other suitable energy source to provide secondary backup energy for thesystem 100. - The
impedance detection module 126 is in communication with thesignal conditioning module 122 and thepower management module 124, and functions to enable detection of a proper interface between the microsensor 116 and body fluid (e.g., interstitial fluid) of the user. In facilitating monitoring of impedance, theimpedance detection module 126 can thus provide signals that indicate that themicrosensor patch 110 is properly coupled to the user (e.g., interfacing with interstitial fluid and experiencing an ˜80% moisture environment) or improperly coupled to the user (e.g., not interfacing properly with interstitial fluid and experiencing a low-moisture environment). Signals from theimpedance detection module 126 can further be used to trigger an error correction action (e.g., notification for the user to reapply themicrosensor patch 110, automatic manipulation of themicrosensor patch 110 to re-establish interface with body fluid, etc.). In one variation, as shown inFIG. 4 , the impedance detection module can comprise electronic circuitry configured to communicate with themultiplexer 22, theADC 24, and thepower management module 124, in receiving an impedance signal from themicrosensor 116. However, theimpedance detection module 126 can additionally or alternatively be configured relative to other elements of theelectronics subsystem 120 in any other suitable manner. - In generating the impedance signal, the
impedance detection module 126 can be configured to detect impedance between two electrodes of the array offilaments 117 in response to an applied voltage provided in cooperation with thepower management module 126 and themicroprocessor 113. In one variation, wherein themicrosensor 116 comprises a first workingelectrode 11, a second workingelectrode 12, acounter electrode 13, and a reference electrode, theimpedance detection module 126 can be configured to detect impedance from two of the first workingelectrode 11, the second workingelectrode 12, thecounter electrode 13, and thereference electrode 14, examples of which are shown inFIG. 7 . In a specific example, an applied signal can be injected into the system in a working electrode and detected in thereference electrode 14. However in other configurations of themicrosensor 116, theimpedance detection module 126 can be configured to detect impedance from electrodes of themicrosensor 116 in any other suitable manner. - In relation to the applied voltage used for generation and reception of the impedance signal (i.e., for purposes of perturbation), the
electronics subsystem 120 is preferably configured to provide an applied voltage waveform having a characteristic value (e.g., average value) near the operating potential of thesignal conditioning module 122 of theelectronics subsystem 120. In a variation wherein the signal conditioning module 122 (e.g., an analogfront end 23 of the signal conditioning module 122) operates at a shifted potential relative to a potential of an electrode of the microsensor 116 (e.g., a reference potential of a reference electrode), the applied voltage waveform preferably has a characteristic value (e.g., average value) near or equal to that of the shifted potential, in order to improve stability of the microsensor no when switching back to a current sensing mode (i.e., the primary detection mode). The offset (i.e., shifted potential) is configured to reduce or minimize any disruption to signal integrity when the microsensor no is switched from a current sensing mode to an impedance detection mode, and then back to a current sensing mode. In a specific example, as shown inFIG. 8 , the applied voltage waveform is shifted about a characteristic value and has a frequency from 50-200 kHz, in relation to a shifted potential of the analogfront end 23 relative to thereference electrode 14. However, the applied voltage can alternatively have any other suitable characteristics (e.g., characteristic voltage values, frequencies, etc.) defined in relation to the operating potential(s) of any other suitable element of theelectronic subsystem 120 related to themicrosensor 116. - In relation to triggering of a measurement using the
impedance detection module 126, triggering can occur with any suitable frequency (e.g., in relation to the lifespan of usage of the system 100), any suitable regularity (e.g., at regular time intervals, at irregular time intervals, etc.), and/or upon any suitable triggering event. In one variation, theimpedance detection module 126 can be configured to provide an impedance signal in association with monitoring of an electrode (e.g., monitoring voltage of the counter electrode 13) of themicrosensor 116, wherein detection of an out-of-range parameter (e.g., voltage) of the electrode triggers the applied voltage waveform and generation of an impedance signal. As such, theelectronics subsystem 120 and the processing subsystem 160 (described further below) can be configured to cooperate in continuously detecting a voltage parameter of thecounter electrode 13, and theelectronics subsystem 120 can be configured to apply the applied voltage waveform and detect the impedance signal when the voltage parameter of the counter electrode satisfies a voltage threshold condition. - Additionally or alternatively, in another variation, the
impedance detection module 126 can be configured to provide an impedance signal upon initial application of thesystem 100 to the body of the user. Additionally or alternatively, in another variation, theimpedance detection module 126 can be configured to provide impedance signals at regular time intervals (e.g., once every hour) over the course of use of thesystem 100 by the user. Additionally or alternatively, in relation to other sensors (e.g., of a mobile computing device associated with the user and thesystem 100, of a wearable computing device associated with the user and thesystem 100, of thesystem 100, etc.) theimpedance detection module 126 can be configured to provide an impedance signal in response to a sensor signal that indicates performance of an action by the user. For instance, monitoring of signals provided by an accelerometer and/or gyroscope can be used to indicate that the user is exercising, and that an impedance measurement should be taken (e.g., during exercise, after exercise, etc.) to ensure proper coupling of thesystem 100 to the user. In another example, monitoring of body temperature of the user can be used to indicate that the user is showering, and that an impedance measurement should be to ensure proper coupling of thesystem 100 to the user. Theimpedance detection module 126 can, however, be configured in any other suitable manner. - The
impedance detection module 126 can further be used to generate notifications pertaining to impedance signal measurements that indicate improper coupling. For instance, a notification can be generated (and transmitted to a mobile computing device of the user) in response to detection of unsuitable impedance derived from comparison between the impedance signal and an impedance threshold condition. However, use of the impedance signal in performing an error correction action can be performed in any other suitable manner. - The transmitting
unit 130 functions to receive signals generated by the microsensor patch 110 (e.g., by way of the microprocessor 113), and to interface with at least one of amobile computing device 150, a data processing and/or storage module (e.g., a module external to an on-board storage module, a cloud-based computing module, etc.) by outputting signals based on at least one analyte parameter. The transmittingunit 130 thus cooperates with other elements of theelectronics subsystem 120 to transmit signals based on sensed analyte parameters, which can be used to facilitate analyses of the user's body chemistry. In variations, the transmittingunit 130 includes anantenna 132, aradio 134 coupling the antenna to themicroprocessor 113, and can additionally or alternatively include a linking interface 136 (e.g., wireless or wired interface, as described in further detail below). - Preferably, the transmitting
unit 130 and the microsensor patch no are integrated as a cohesive unit; however, the transmittingunit 130 and the microsensor patch no can alternatively form a modular unit, wherein one of the transmittingunit 130 and themicrosensor patch 110 is disposable, and wherein one of the transmittingunit 130 and the microsensor patch no is reusable. In variations of the microsensor patch no and the transmittingunit 130, elements of the microsensor patch no aside from themicrosensor 116 can alternatively be integrated with the transmittingunit 130, such that the transmittingunit 130 is configured to be reusable and themicrosensor 116 of themicrosensor patch 110 is configured to be disposable. Modularity in thesystem 100 is described in further detail in relation to thehousing 190 below. - Additionally, the transmitting
unit 130 is preferably configured to output signals based on at least one analyte parameter characterizing body chemistry continuously over the lifetime usage of the transmittingunit 130; however, the transmittingunit 130 can alternatively be configured to output signals based on at least one analyte parameter at a set of time points (e.g., minutes, hours, days). Still alternatively, the transmittingunit 130 can be configured to output signals in a manner that does not interfere with other operations (e.g., signal collection operations) of theelectronics subsystem 120. In one such example, the transmittingunit 130 can be configured to stop signal transmission whenever theADC 24 is collecting signal data from themicrosensor 116, in coordination with timing enabled by a clock/watchdog module associated with themicroprocessor 113. In variations, the transmittingunit 130 can be further configured to output signals upon a user prompt, and/or can comprise a variable sampling rate. For example, the sampling rate can be lower when user is asleep, higher during activity (e.g., exercise), higher when there is a sudden change in a value, higher in response to other stimuli (e.g., if glucose spikes, sampling rate increases for all analytes). - The
antenna 132 of the transmittingunit 130 functions to convert electrical signals from the microsensor patch no into radio waves, to facilitate communication with one or more devices external to the microsensor patch no and/or transmittingunit 130 assembly (e.g., by a Bluetooth Low Energy connection). Theantenna 132 preferably interfaces with aradio 134 coupled to themicroprocessor 113, as shown inFIG. 4 , but can additionally or alternatively interface with other elements of the transmittingunit 130. The antenna is preferably an omnidirectional antenna that radiates radio wave power uniformly primarily in one plane, with the power decreasing with elevation angle relative to the plane; however, the antenna can alternatively be an isotropic antenna that has a spherical radiation patent. Other variations of the antenna can include any appropriate antenna that can be integrated with the form factor of the transmitting unit, while providing appropriate communication with external devices. - The
radio 134 functions to transmit and receive signals from theantenna 132, and also facilitates communication with elements of the transmittingunit 130 and external devices. Theradio 134 and theantenna 132 can additionally or alternatively be supplemented with a linkinginterface 136, as described in further detail below, but can additionally or alternatively interface with other elements of theelectronics subsystem 120. - The linking
interface 136 functions to transmit an output of at least one element of the microsensor patch no/transmittingunit 130 assembly to amobile computing device 150. Additionally, the linkinginterface 136 can function to transmit and output of at least one element of themicrosensor patch 110 and transmittingunit 130 assembly to another element external to themicrosensor patch 110 and transmittingunit 130. Preferably, the linkinginterface 136 is a wireless interface; however, the linkinginterface 136 can alternatively be a wired connection. In a first variation, the linkinginterface 136 can include a first module that interfaces with a second module included in amobile computing device 150 or other external element (e.g., wrist-borne mobile computing device, head-mounted mobile computing device), wherein data or signals (e.g., microsensor or transceiver outputs) are transmitted from the transmittingunit 130 to themobile computing device 150 or external element over non-wired communications. The linkinginterface 136 of the first variation can alternatively implement other types of wireless communications, such as 3G, 4G, radio, or Wi-Fi communication. In the first variation, data and/or signals are preferably encrypted before being transmitted by the linkinginterface 136. For example, cryptographic protocols such as Diffie-Hellman key exchange, Wireless Transport Layer Security (WTLS), or any other suitable type of protocol can be used. The data encryption can also comply with standards such as the Data Encryption Standard (DES), Triple Data Encryption Standard (3-DES), or Advanced Encryption Standard (AES). In variations with data encryption, data can be unencrypted upon transmission to themobile computing device 150 associated with the user. However, in an alternative variation, data can remain encrypted throughout transmission to a mobile computing device (associated with the user, not associated with the user) and unencrypted at another module of a processing subsystem 160 (e.g., unencrypted in the cloud), wherein information derived from analysis of the data can then be transmitted back to the mobile computing device associated with the user in a secure manner. In this variation, a user can thus pair his/hermicrosensor patch 110 with a mobile computing device unassociated with the user for transmission of encrypted data, and then later receive personalized body information at his/her ownmobile computing device 150 after processing in the cloud. - In a second variation, the linking
interface 136 is a wired connection, wherein the linkinginterface 136 includes a wired jack connector (e.g., a ⅛″ headphone jack, a USB connection, a mini-USB connection, a lightning cable connection, etc.) such that the transmittingunit 130 can communicate with themobile computing device 150 and/or an external element through a complementary jack of the mobile device and/or external element. In one specific example of the linkinginterface 136 that includes a wired jack, the linking interface is configured only to transmit output signals from the transmittingunit 130/microsensor patch 110. In another specific example, the linkinginterface 136 is configured to transmit data to and from at least one element of transmittingunit 130/transdermal path no assembly and amobile computing device 150. In this example, the linkinginterface 136 can transmit output signals into themobile computing device 150 through an input of the jack of themobile computing device 150 and can retrieve data from an output of the jack of themobile computing device 150. In this example, the linkinginterface 136 can communicate with themobile computing device 150 via inter-integrated circuit communication (I2C), one-wire, master-slave, or any other suitable communication protocol. However, the linking interface can transmit data in any other way and can include any other type of wired connection that supports data transfer between the transmittingunit 130 and/ormicrosensor patch 110, and themobile computing device 150. - As noted above, the
electronics subsystem 120 can include any other suitable module(s) and/or be configured in any other suitable manner. For instance, theelectronics subsystem 120 can include or be in communication with an actuator configured to automatically perform an action (e.g., vibration, provision of a biasing force) that biases the microsensor into communication with interstitial fluid of the user, in response to detection of unsuitable impedance derived from comparison between an impedance signal and an impedance threshold condition. - The
housing 190 supports themicrosensor 116 and theelectronics subsystem 120, and functions to facilitate robust coupling of themicrosensor patch 110 to the user in a manner that allows the user to wear the microsensor patch no for a sufficient period of time (e.g., one week, one month, etc.). Thehousing 190 can also function to protect elements of the microsensor patch no from physical damage over the lifetime usage of themicrosensor patch 110. Preferably, at least one portion of thehousing 190 is flexible to facilitate adhesion to the user and compliance with skin of the user as the user moves in his/her daily life; however, at least a portion of thehousing 190 can alternatively be rigid in order to provide more robust protection against physical damage. In an embodiment where a portion of thehousing 190 is flexible, other elements of the microsensor patch no can also be flexible (e.g., using a thin film battery, using flexible electronics, etc.) to facilitate adhesion to the user and compliance as the user moves about in his/her daily life. In one variation, thehousing 190 can comprise a single unit that entirely houses themicrosensor 116 and theelectronics subsystem 120. In this variation, thehousing 190 can be configured to couple to the user using any suitable coupling mechanism (e.g., adhesive coupling mechanism, strap-based coupling mechanism, etc.). However, in other variations, thehousing 190 can alternatively be modular and comprise a set of portions, each portion configured to enable coupling of themicrosensor 116 to the user and/or to house elements of theelectronics subsystem 120. Modularity of thehousing 190 can thus allow portions of thesystem 100 to be disposable and/or reusable. - In one such modular variation of the
housing 190, as shown inFIG. 9 , the housing can comprise afirst housing portion 191 and asecond housing portion 196, wherein thefirst housing portion 191 is configured to facilitate coupling of filaments of themicrosensor 116 to the user, and thesecond housing portion 196 is configured to house elements of theelectronics subsystem 120 and to couple theelectronics subsystem 120 to themicrosensor 116 by way of thefirst housing portion 191. As such, thefirst housing portion 191 and thesecond housing portion 196 of this variation are preferably configured to mate with each other in a complementary manner (e.g., with a male-female coupling mechanism, with a magnetic coupling mechanism, with a latch-based coupling mechanism, with a lock-and-key based coupling mechanism, etc.). In a specific example, as shown inFIGS. 10A-10B , thefirst housing portion 191′ includes anopening 192′, and asecond housing portion 196′ is insertable into the opening of the first housing portion in a first configuration, wherein coupling between thefirst housing portion 191′ and thesecond housing portion 196′ provides a hermetic seal between thefirst housing portion 191 and thesecond housing portion 196. In more detail, as shown inFIG. 10C , thefirst housing portion 191 can include an o-ring 193 (e.g., an o-ring molded onto the material of the first housing portion) at a perimeter of theopening 192, and a perimeter region of thesecond housing portion 196 can include a recessed region 197 that interfaces with the o-ring 193 in a manner that provides a hermetic seal. In this specific example, theopening 192 and thesecond housing portion 196 each have substantially circular footprints; however, theopening 192 and thesecond housing portion 196 can additionally or alternatively have any other suitable footprints or be configured in any other suitable manner. - In the specific example, as shown in
FIGS. 10A-10B , thefirst housing portion 191′ can comprise anadhesive substrate 91 having amicrosensor opening 92, amicrosensor interface substrate 93 superior to the adhesive substrate and configured to pass themicrosensor 92 through themicrosensor opening 92, acoupling ring 94 configured to retain the position of themicrosensor interface substrate 93 relative to theadhesive substrate 91 and to provide an interface for mating with thesecond housing portion 196, and aflexible cover 95 ensheathing thecoupling ring 94, coupled to theadhesive substrate 91, and configured to maintain coupling between theadhesive substrate 191, themicrosensor interface substrate 93, and thecoupling ring 94. In relation to the configuration described above, theadhesive substrate 91 is configured to facilitate adhesion of themicrosensor patch 110 to the user at an inferior surface of the adhesive substrate, and theflexible cover 95 is configured to provide theopening 192′ that receives thesecond housing portion 192. - The
second housing portion 196 of the specific example is rigid, and configured to form a shell about theelectronics subsystem 120, while including openings that provide access for a set ofcontacts 98 that interface theelectronics subsystem 120 with themicrosensor interface substrate 93 when thefirst housing portion 191 is coupled to thesecond housing portion 196. In relation to themicrosensor interface substrate 93 of thefirst housing portion 191, and in relation to a circular (or otherwise axially symmetric) configuration of an interface between thesecond housing portion 196 and theopening 192 of thefirst housing portion 191, themicrosensor interface substrate 93 of the specific example can include a circular printed circuit board comprising a set ofconcentric ring contacts 97, as shown inFIG. 10A , that interface electronics of thesecond housing portion 196 with filaments of themicrosensor 116. As such, the set of contacts 98 (e.g., digital contacts) of electronics of thesecond housing portion 196 can properly interface with themicrosensor 116 in any rotational position of thesecond housing portion 196 within thefirst housing portion 191, as shown inFIG. 10B . In alternative variations of this specific example however, orientation-unspecific coupling between thefirst housing portion 191 and thesecond housing portion 196 can be achieved in any other suitable manner. In still alternative variations of this specific example, thefirst housing portion 191 and thesecond housing portion 196 can be configured to couple with a set orientation in order to ensure proper communication between the microsensor 116 and theelectronics subsystem 120. - In variations of the
housing 190 comprising afirst housing portion 191 and asecond housing portion 196, thefirst housing portion 191 and thesecond housing portion 196 can be coupled together and/or coupled to the user by way of apatch applicator 180, as described in further detail below. Furthermore, other variations of modularity can comprise any other suitable distribution of themicrosensor 116 and elements of theelectronics subsystem 120 across portions of the housing in any other suitable manner. For instance, in one such variation, themicrosensor 116, themultiplexer 22, and the analogfront end 93 of theelectronics subsystem 120 can be coupled to a separate battery (e.g., a thin film battery) within a disposable portion of thehousing 190, and other elements of theelectronics subsystem 120 can be supported by a reusable portion of thehousing 190. The system 10 o can, however, comprise any other suitable distribution of elements across thehousing 190 in a modular fashion. - The processing subsystem 16 o is in communication with the
electronics subsystem 120 and functions to generate analyses pertaining to the user's body chemistry, and to transmit information derived from the analyses to the user at an electronic device associated with the user. As shown inFIG. 1 , theprocessing subsystem 160 can be implemented in one or more of: a computer machine, a remote server, a cloud computing system, a microprocessor, processing hardware of a mobile computing device (e.g., smartphone, tablet, head-mounted mobile computing device, wrist-borne mobile computing device, etc.) and any other suitable processing system. In one variation, theprocessing subsystem 160 comprises afirst module 161 configured to generate an analysis indicative of an analyte parameter of the user and derived from a signal stream from themicrosensor 116 and an impedance signal from theelectronics subsystem 120. Additionally, in this variation, theprocessing subsystem 160 comprises asecond module 162 configured to render information derived from the analysis at an electronic device (e.g., mobile computing device 150) associated with the user, thereby facilitating monitoring of body chemistry of the user. In this variation, the modules of theprocessing subsystem 160 can be implemented in a hardware module and/or a software module. In variations, asoftware module 163 can be implemented, at least in part, as a native software application executing on amobile computing device 150 associated with the user, wherein the user has a user account associated with the native software application. - In more detail, the
software module 163 functions to analyze an output provided by the transmittingunit 130 of theelectronics subsystem 120, and to communicate an analysis of the output back to the user, so that the user can monitor his/her body chemistry. Preferably, thesoftware module 163 analyzes at least one analyte parameter in order to determine a metric providing information about a user's body chemistry. In one variation, the software module can determine that a body analyte parameter (e.g., glucose level) of the user is too low or less than ideal, and facilitate a behavior change in the user by providing a body chemistry metric indicating a hypoglycemic state. In this variation, the software module can additionally determine that the body analyte parameter (e.g., glucose level) of the user is within a proper range based on a determined metric. The software module of this variation can additionally determine that the body analyte parameter (e.g., glucose level) of the user is too high and facilitate a behavior change in the user by providing a body chemistry metric indicating a hyperglycemic state. - In another example, the software module can analyze an output provided by the transmitting
unit 130 based on a set of parameters for multiple analytes characterizing a user's body chemistry, at a set of time points, and determine at least one metric based on the set of parameters at the set of time points. The software module can then determine and output at least one of a temporal trend in a metric, a temporal trend in an analyte parameter, absolute values of a metric, changes in value of a metric, absolute values of an analyte parameter, and changes in value of an analyte parameter. Thesoftware module 163 in this example can further be configured to communicate a suggestion to the user based on an analysis determined from the set of parameters for multiple analytes. - The software module preferably incorporates at least one of user health condition, user characteristics (e.g., age, gender, ethnicity), and user activity in analyzing an output provided by the transmitting
unit 130. In one specific example, if a user sets a desired body glucose level range, which is entered into the software module, the software module can be configured to facilitate provision of alerts notifying the user of short-term risks (e.g., diabetic crash), long-term risks (e.g., worsening diabetic condition), and risk of exiting the desired body glucose level range. In another specific example, the software module can compare analyte parameters and/or a metric characterizing the user's body chemistry to other users with similar health conditions or characteristics (e.g., age, gender, ethnicity). In yet another example, the software module can be able to correlate at least one analyte parameter or metric to a user activity, such that the user is provided with information relating a value of the analyte parameter and/or metric to an activity that he or she has performed. The software module can additionally or alternatively provide an analysis that includes any other health- and/or user-related information that can be useful in treating, maintaining, and/or improving a health condition of a user. - As shown in
FIGS. 1, 11A, and 11B , the software module can be implemented, at least in part, as an application executable on amobile computing device 150. As described above, themobile computing device 150 is preferably a smartphone but can also be a tablet, laptop computer, PDA, e-book reader, head-mounted computing device, smart-watch, or any other mobile device. The software module can alternatively be an application executable on a desktop computer or web browser. The software module preferably includes an interface that accepts inputs from the user (e.g., user health condition, user characteristics, user activity), and uses these inputs in analyzing an output provided by the transmittingunit 130. Preferably, the software module also includes an interface that renders an analysis based on sensed analytes and/or user inputs in some form. In an example, the software module includes an interface that summarizes analyte parameter values in some manner (e.g., raw values, ranges, categories, changes), provides a trend (e.g., graph) in at least one analyte parameter or body chemistry metric, provides alerts or notifications, provides additional health metrics, and provides recommendations to modify or improve body chemistry and health metrics. In another example, the software module can implement two interfaces: a first interface accessible by a user, and a second interface accessible by a health care professional servicing the user. The second interface can provide summarized and detailed information for each user that the health care professional interacts with, and can further include a message client to facilitate interactions between multiple users and the health care professional. The software module can additionally or alternatively access a remote network or database containing health information of the user. The remote network can be a server associated with a hospital or a network of hospitals, a server associated with a health insurance agency or network of health insurance agencies, a server associated with a third party that manages health records, or any other user- or heath-related server or entity. The software module can additionally or alternatively be configured to accept inputs from another entity, such as a healthcare professional, related to the user. - The
software module 163 can additionally or alternatively execute fully or in part on a remote server. In a first variation, the software module can be a cloud-computing-based application that performs data analysis, calculations, and other actions remotely from themobile computing device 150. In one example of the first variation, themobile computing device 150 can receive an output of the transmittingunit 130 via the linkinginterface 136 and then transfer the output to the remote server upon which the software module executes. In the first variation, signals are preferably transferred via a wireless connection, such as a Bluetooth connection, 3G or 4G cellular connection, and/or via a Wi-Fi internet connection. In another example of the first variation, amobile computing device 150 can function to transmit data to and/or receive data from the software module. In a second variation, the software module can include a first software component executable on amobile computing device 150, such as an application that manages collection, transmission, retrieval, and/or display of data. In the second variation, the software module can further include a second software component that executes on the remote server to retrieve data, analyze data, and/or manage transmission of an analysis back to themobile computing device 150, wherein the first software component manages retrieval of data sent from the second software component and/or renders of a form of the analysis on a display of themobile computing device 150. However, the software module can include any number of software components executable on anymobile computing device 150, computing device, and/or server and can be configured to perform any other function or combination of functions. - As shown in
FIG. 12A , thesoftware module 163 can further be integrated with anotification module 165 configured to provide an alert or notification to a user and/or health care professional based on the analysis of the output. Thenotification module 165 functions to access an analysis provided by the software module and to control transmission of anotification 166 to at least one of a user and a healthcare profession interacting with the user. In one variation, thenotification module 165 receives an analysis of the software module being executed on amobile computing device 150, and generates anotification 166 based upon the analysis. In this variation, a form of the analysis is preferably transmitted from the software module, executing on themobile computing device 150, to thenotification module 165, wherein themobile computing device 150 accesses the analysis either from the software module executing on themobile computing device 150 or from the software module executing on a remote server and in communication with themobile computing device 150. Thenotification module 165 preferably controls transmission of thenotification 166 to the user, such as by triggering a display of themobile computing device 150 to display a form of the notification, or by generating and/or transmitting an email, SMS, voicemail, social media platform (e.g., Facebook or Twitter) message, or any other message accessible by the user and which contains thenotification 166. Thenotification module 165 can also convey thenotification 166 by triggering a vibration of themobile device 160, and/or by altering the state (i.e., ON or OFF) of one or more light sources (e.g., LEDs) of themobile computing device 150. However, thenotification module 165 can alternatively manage the transmission of any other information and function in any appropriate manner. - The
notification 166 preferably contains information relevant to a body chemistry status of the user. Thenotification 166 can additionally include an explicit directive for the user to perform a certain action (e.g., eat, rest, or exercise) that affects the body chemistry of the user. Therefore, thenotification 166 preferably systematically and repeatedly analyzes a body chemistry status of the user based on at least one analyte parameter of the user and provides and alert and/or advice to manage and monitor a user's body chemistry substantially in real time. In one example, thenotification 166 can further include information related to what or how much to eat, where and how long to run, level of exertion, and/or how to rest and for how long in order to appropriately adjust body chemistry. In other examples, thenotification 166 can include any appropriate information relevant to monitoring a body chemistry metric of the user. - In still other examples, as shown in
FIG. 12B , thenotification 166 can indicate one or more of: a current level of a measured analyte (e.g., represented in hue, represented in saturation, represented in intensity, etc. of a graphical rendering); a trending direction for the level of the measured analyte (e.g., represented in a feature gradient within a graphical rendering); a lower bounding level and an upper bounding level between which the level of the measured analyte is traversing; a trending direction of a level of a measured analyte (e.g., represented in an arrow of a graphical rendering); a quantification of a level of a measured analyte (e.g., represented as rendered text); a summary of a level of a measured analyte (e.g., represented as rendered text); a percent of time within a time duration (e.g., one day) that the level of the measured analyte is within a target range (e.g., healthy range); and historical behavior of a level of a measured analyte (e.g., represented as historical “ghosting” of a rendering based upon a previous analyte level). - Additionally or alternatively, in still other examples, as shown in
FIG. 12C , thenotification 166 can include a graphical rendering that shows analyte data from past to present using a line graph representation, wherein an amount (e.g., concentration) of the analyte is represented along a first axis and time is represented along a second axis. In these examples, the graphical rendering can further include a “predicted region” based upon the analysis of theprocessing subsystem 160, wherein the predictedregion 66 depicts a prediction of where the analyte level will be at a future time point, and a width of the predictedregion 66 indicates confidence in the prediction. - In relation to the
processing subsystem 160 and analyses generated at theprocessing subsystem 160, theprocessing subsystem 160 can be coupled to or comprise adata storage unit 170, as shown inFIG. 13 . Thedata storage unit 170 functions to retains data, such as an analysis provided by a software module, anotification 166, and/or any other output of any element of thesystem 100. Thedata storage unit 170 can be implemented with themicrosensor patch 110, transmittingunit 130,mobile computing device 150, personal computer, web browser, external server (e.g., cloud), and/or local server, or any combination of the above, in a network configured to transmit, store, and receive data. Preferably, data from thedata storage unit 170 is automatically transmitted to any appropriate external device continuously; however, data from thedata storage unit 170 can alternatively be transmitted only semi-continuously (e.g., every minute, hourly, daily, or weekly). In one example, data generated by any element can be stored on a portion of thedata storage unit 170 when the linkinginterface 136 is not coupled to an element external to the microsensor patch no/transmittingunit 130 assembly. However, in the example, when a link is established between the linkinginterface 136 and an external element, data can then be automatically transmitted from thestorage unit 170. In other examples, thedata storage unit 170 can alternatively be prompted to transmit stored data by a user or other entity. Operation modes related to device pairing and information transfer are further described in relation to the base station of Section 1.4 below. - As shown in
FIG. 1 , thesystem 100 can further comprise apatch applicator 180, which functions to facilitate application of at least one of themicrosensor patch 110 and the transmittingunit 130. Thepatch applicator 180 preferably accelerates the a portion of the housing with themicrosensor 116 toward skin of the user, thereby causing themicrosensor 116 to penetrate skin of the user and sensing regions of the microsensor to access interstitial fluid of the user. However, thepatch applicator 180 can additionally or alternatively facilitate coupling of themicrosensor 116 to the user using one or more of: skin stretching, skin permeabilization, skin abrasion, vibration, and/or any other suitable mechanism, variations of which are shown inFIGS. 14A-14C . In a first variation, as shown inFIG. 15A , thepatch applicator 180′ can be incorporated into afirst housing portion 191 of ahousing 190 of thesystem 100 and can comprise an elastic pin 181 (e.g., spring-loaded pin) configured to complement a recess of asecond housing portion 196. In this variation, a normal force applied to a broad surface of thesecond housing portion 196 initially causes theelastic pin 181 to retract, and rebounding of theelastic pin 181 into the recess of thesecond housing portion 196 biases and accelerates themicrosensor 116 into the skin of the user. - In a second variation, as shown in
FIG. 15B , thepatch applicator 180″ implements elastic portions of thehousing 190, which can be used to retract a housing portion with themicrosensor 116 and to release the housing portion, thereby accelerating themicrosensor 116 into skin of the user. - In a third variation, the patch applicator cooperates with a
first housing portion 191 and asecond housing portion 196, wherein the patch applicator comprises a first applicator portion configured to surround thehousing 190 and interface with thesecond housing portion 196, and a second applicator portion configured to accelerate the second housing portion toward skin of the user. In a first specific example of the third variation, as shown inFIG. 16A , thepatch applicator 180 a comprises a ram-and-catch mechanism, wherein twisting of arotatable component 83 of thepatch applicator 180 a transitions aplunger 84 of thepatch applicator 180 a from a restingconfiguration 84 a to a loadedconfiguration 84 b, as shown inFIGS. 16B and 16C , and pushing of therotatable component 83 of thepatch applicator 180 a releases theplunger 84 back to the restingconfiguration 84 a (as shown inFIG. 16D ), thereby accelerating themicrosensor 116 toward skin of the user during application of the microsensor patch no to the user. In more detail, in the first specific example, twisting of therotatable component 83 transitions theplunger 84 along rampedsurfaces 85 of thepatch applicator 180 a to the loadedconfiguration 84 a, where theplunger 84 rests ontriggers 86 of thepatch applicator 180 a. Then, as shown inFIG. 16D , pressing of therotatable component 83 provides an outward biasing force on the triggers 86 (e.g., due to wedge-shaped morphology of the triggers that interacts with a complementary portion of the rotatable component 83), thereby releasing theplunger 84 to the restingconfiguration 84 a. In this specific example, a set ofribs 87 coupled to a wall of thepatch applicator 180 surrounding theplunger 84 maintain plunger alignment. - In a second specific example of the third variation, as shown in
FIG. 17 , the patch applicator 180 b comprises anelastic component 89 housed within and coupled to a translatingcomponent 88 of the patch applicator 180 b, wherein the translatingcomponent 88 comprises aplunger 84′ and is configured to translate along a first axis. The patch applicator 180 b further comprises atrigger 188 coupled to abiasing spring 189 and configured to translate along a second axis perpendicular to the first axis, between a holding position 188 a and a releasing position 188 b. In the second specific example, the translatingcomponent 88 is biased in holding position 188 a, and pushing of the translatingcomponent 88 places a lateral biasing force on thetrigger 188 against the biasing spring 189 (e.g., due to wedge-shaped morphology of thetrigger 188 that interacts with a complementary portion of the translating component 88), thereby releasing theplunger 84′ to accelerate themicrosensor 116 toward skin of the user. In pushing the translatingcomponent 88, compression of theelastic component 89 creates a reverse biasing force that automatically releases the translatingcomponent 88 toward the resting configuration 88 a. - The
patch applicator 180 can alternatively be configured to receive themicrosensor patch 110, to stretch the skin of the user isotropically in two dimensions to facilitate application, and to push the microsensor patch no/transmittingunit 130 assembly onto the user's stretch skin. Still alternatively, thepatch applicator 180 can include any other suitable applicator, variations and examples of which are described in U.S. App. No. 62/025,174 entitled “System for Monitoring Body Chemistry” and filed on 16 Jul. 2014. Still other variations of thesystem 100 can entirely omit apatch applicator 180. - As shown in
FIG. 1 , the system can include abase station 5 that functions to receive the microsensor patch 110 (e.g., within a second housing portion 196). In receiving themicrosensor patch 110, thebase station 5 can include alignment elements 6 (e.g., protrusions, recesses, magnetic alignment elements, etc.) that facilitate alignment of themicrosensor patch 110 within the base station, as shown inFIG. 18A . Thebase station 5 can additionally or alternatively facilitate charging of a rechargeable battery of themicrosensor patch 110 by including elements that generate an electromagnetic field that interacts with a charging coil coupled to the battery, thereby charging thebattery 138. Thebase station 5 can additionally or alternatively be used to transition the microsensor patch between different operational states, in relation to data transfer between themicrosensor patch 110, amobile computing device 150 associated with the user, and modules of a processing subsystem 160 (e.g., cloud module) as shown inFIG. 19 . In afirst operation mode 5 a, the transmittingunit 130 of themicrosensor patch 110 and themobile computing device 150 can pair/bond only when thesecond housing portion 196 of themicrosensor patch 110 is in communication with the base station 5 (e.g., aligned within the base station 5). Thus, in thefirst operation mode 5 a, themicrosensor patch 110 can transmit and receive data (e.g., compact raw data compounded into a plurality of bits over Bluetooth communication). In asecond operation mode 5 b wherein themicrosensor patch 110 is not in communication with thebase station 5, themicrosensor patch 110 can be configured to only transmit data (but not receive data), thereby reducing energy usage, preventing man-in-the-middle attack, and preventing tampering. As such, thesecond operation mode 5 b prevents reading of data from themicrosensor patch 110 by a fraudulent entity, without gaining physical access to themicrosensor patch 110. - The operation modes of the
system 100 enabled by the microsensor patch, thebase station 5, themobile computing device 150, and theprocessing subsystem 160 are further detailed inFIG. 19 . In relation to pairing with themicrosensor patch 110 in thefirst operation mode 5 a, themobile computing device 150 functions to provide one or more of: data relay, data visualization, data storage, notification, and action functions (e.g., as described in relation to thesoftware module 163 described above). In communicating information between themobile computing device 150 and a cloud module of theprocessing subsystem 160, themobile computing device 150 can be configured to transmit raw data in Javascript Object Notation (JSON) format (or any other suitable format) to be processed in the cloud, and analyte data, notifications, and alerts (e.g., as derived from an analysis) can be transmitted back to themobile computing device 150 in JSON format (or any other suitable format). The cloud module of theprocessing subsystem 160 can thus serve to enable authentication of the user (e.g., in association with a user account of a native application) and/or data, data storage, data processing, notification, and prediction functions, as described in relation to theprocessing subsystem 160 described above. Thus, thesystem 100 is configured for fault tolerance, wherein themicrosensor patch 110 stores data when faulty operation of themobile computing device 150 occurs, and failure of theprocessing subsystem 100 results in data storage at the mobile computing device. Thesystem 100 can, however, be configured in any other suitable manner. - As shown in
FIG. 18B , thebase station 5 and thepatch applicator 180 can be configured to couple together, thus facilitating portability of thebase station 5 andpatch applicator 180. However, thebase station 5,patch applicator 180, and microsensor no can alternatively be configured to couple or not couple together in any other suitable manner. - The
microsensor patch 110 is preferably calibrated to prevent signal degradation and to mitigate the effects of transient effects experienced during analyte sensing. The primary sensing mechanism is potentiometric for small analytes (e.g., potassium, sodium, calcium), and amperometric for large molecules (e.g., glucose, lactic, creatinine). In a first variation, the microsensor patch no passively detects analytes by detecting an impedance and/or capacitance change, as well as a voltage change when an analyte or analyte concentration contacts themicrosensor 116. Calibration can occur by normalizing sensing measurements relative to a grounded portion of themicrosensor 116, such as a reference electrode. - In a second variation, the
microsensor patch 110 can implement active impedance calibration, wherein a drive voltage is implemented by the electronics subsystem 111 of themicrosensor patch 110, and voltage and impedance and/or capacitance changes are detected. The drive voltage is preferably applied in a sinusoidal pattern, but can alternatively be applied in any appropriate pattern. In the second variation, sensed analytes or analyte concentrations are characterized by changes in impedance, and noise is characteristically distinguished from analyte detection by monitoring changes in voltage unaccompanied by changes in impedance or capacitance. The second variation thus employs a conductometric measurement to calibrate themicrosensor patch 110. Impedance measurements can also be used to address shift in a reference electrode (e.g., in the first variation described above). - In a third variation, the microsensor patch no can employ injection of a volume of a calibration solution with a known concentration of at least one analyte, in order to calibrate the
microsensor patch 110. In an example of the third variation, the calibration solution can have a known concentration of at least one analyte, such that changes (e.g., changes in electrical parameters) detected by the microsensor patch no in response to the calibration solution can be used to normalize measurements resulting from sensed analytes or analyte concentrations occurring after injection of the volume of calibration solution. In the third variation, the calibration solution can be injected automatically and periodically over the lifetime usage of the transdermal patch; however, the calibration solution can alternatively be injected when prompted by a user or other entity. - In a fourth variation, the
microsensor patch 110 can include a membrane comprising a known concentration and/or release profile of at least one analyte, in order to calibrate the microsensor patch no. In an example of the fourth variation, the membrane can have a known concentration and release profile of at least one analyte, such that changes (e.g., changes in electrical parameters) detected by themicrosensor patch 110 in response to the membrane can be used to normalize measurements resulting from sensed analytes or analyte concentrations. In the fourth variation, the membrane can be a degradable membrane, such that degradation of the membrane over time releases analytes from the membrane. Alternatively, the membrane can be manufactured with specific porosity, contributing to a certain analyte release profile. - In a fifth variation, the microsensor patch no can include a coating or a cap comprising a soluble species (e.g., analyte/ion) with a well-known solubility, in order to calibrate the microsensor patch no. In an example of the fifth variation, the soluble species maintains a known concentration of the species within the vicinity of a filament that can be used to normalize and/or calibrate a signal. Examples of soluble species include low solubility, biocompatible calcium salts, such as calcium carbonate, calcium phosphate, and dicalcium phosphate for calcium sensing. Other suitable soluble species can be used to calibrate other analytes.
- In alternative variations, the
microsensor patch 110 can use any other suitable calibration method. For instance, the transdermal patch can be pre-staged, prepped, loaded, or activated to have a set calibration state enabling calibration of the system after application to the user within a desired period of time (e.g., an 85 mg/dl calibration state equilibrated after insertion within a period of 2 hours). - As a person skilled in the art will recognize from the previous detailed description and from the figures and claims, modifications and changes can be made to the described embodiments, variations, and examples of the
system 100 without departing from the scope of thesystem 100. - As shown in
FIG. 20 , a method 200 for monitoring body chemistry of a user comprises: receiving a second housing portion into an opening of a first housing portion S210, the first housing portion supporting a microsensor including a first working electrode, a second working electrode, a reference electrode, and a counter electrode, and the second housing portion supporting an electronics subsystem configured to receive a signal stream from the microsensor; after interfacing with the second housing portion, accelerating the second housing portion toward skin of the user S220, thereby delivering sensing regions of the microsensor into interstitial fluid of the user; generating an impedance signal, from two of the first working electrode, the second working electrode, the reference electrode, and the counter electrode, in response to applying a voltage, near a shifted potential different than a reference potential of the reference electrode S230, wherein the shifted potential is associated with a signal conditioning module of the electronics subsystem; at a processing system in communication with the electronics subsystem, receiving the signal stream and the impedance signal S240; at the processing system, generating an analysis indicative of an analyte parameter of the user and derived from the signal stream and the impedance signal S250; and transmitting information derived from the analysis to an electronic device associated with the user, thereby facilitating monitoring of body chemistry of the user S260. - The
method 200 functions to provide continuous monitoring of a user's body chemistry through reception and processing of signals associated with of one or more analytes present in the body of the user, and to provide an analysis of the user's body chemistry to the user and/or an entity (e.g., health care professional, caretaker, relative, friend, acquaintance, etc.) associated with the user. Alternatively, themethod 200 can function to detect a user's body chemistry upon the user's request or sporadically, and/or can provide an analysis of the user's body chemistry only to the user. The method is preferably implemented, at least in part, using an embodiment, variation, or example of elements of thesystem 100 described inSection 1 above; however, themethod 200 can additionally or alternatively be implemented using any other suitable system. - Variations of the
system 100 andmethod 200 include any combination or permutation of the described components and processes. Furthermore, various processes of the preferred method can be embodied and/or implemented at least in part as a machine configured to receive a computer-readable medium storing computer-readable instructions and/or in the cloud. The instructions are preferably executed by computer-executable components preferably integrated with a system and one or more portions of a control module and/or a processor. The computer-readable medium can be stored on any suitable computer readable media such as RAMs, ROMs, flash memory, EEPROMs, optical devices (CD or DVD), hard drives, floppy drives, or any suitable device. The computer-executable component is preferably a general or application specific processor, but any suitable dedicated hardware device or hardware/firmware combination device can additionally or alternatively execute the instructions. - The FIGURES illustrate the architecture, functionality and operation of possible implementations of systems, methods and computer program products according to preferred embodiments, example configurations, and variations thereof. In this regard, each block in the flowchart or block diagrams may represent a module, segment, step, or portion of code, which comprises one or more executable instructions for implementing the specified logical function(s). It should also be noted that, in some alternative implementations, the functions noted in the block can occur out of the order noted in the FIGURES. For example, two blocks shown in succession may, in fact, be executed substantially concurrently, or the blocks may sometimes be executed in the reverse order, depending upon the functionality involved. It will also be noted that each block of the block diagrams and/or flowchart illustration, and combinations of blocks in the block diagrams and/or flowchart illustration, can be implemented by special purpose hardware-based systems that perform the specified functions or acts, or combinations of special purpose hardware and computer instructions.
- As a person skilled in the art will recognize from the previous detailed description and from the figures and claims, modifications and changes can be made to the preferred embodiments of the invention without departing from the scope of this invention defined in the following claims.
Claims (20)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/377,318 US20170086713A1 (en) | 2014-03-13 | 2016-12-13 | System for monitoring body chemistry |
US15/412,229 US20170127984A1 (en) | 2014-03-13 | 2017-01-23 | System for monitoring body chemistry |
US15/876,678 US20180140235A1 (en) | 2014-03-13 | 2018-01-22 | System for monitoring body chemistry |
US17/156,520 US11291390B2 (en) | 2014-03-13 | 2021-01-22 | Wearable microneedle patch |
US17/198,223 US11272866B2 (en) | 2014-03-13 | 2021-03-10 | Wearable microneedle patch |
US17/590,689 US20220151519A1 (en) | 2014-03-13 | 2022-02-01 | System for monitoring body chemistry |
US17/590,673 US20220151518A1 (en) | 2014-03-13 | 2022-02-01 | System for monitoring body chemistry |
US17/681,669 US20220175279A1 (en) | 2014-03-13 | 2022-02-25 | System for monitoring body chemistry |
US17/681,681 US20220233107A1 (en) | 2014-03-13 | 2022-02-25 | System for monitoring body chemistry |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461952594P | 2014-03-13 | 2014-03-13 | |
US201462012874P | 2014-06-16 | 2014-06-16 | |
US201462025174P | 2014-07-16 | 2014-07-16 | |
US14/657,973 US20150257687A1 (en) | 2014-03-13 | 2015-03-13 | System for monitoring body chemistry |
US15/377,318 US20170086713A1 (en) | 2014-03-13 | 2016-12-13 | System for monitoring body chemistry |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/657,973 Continuation US20150257687A1 (en) | 2014-03-13 | 2015-03-13 | System for monitoring body chemistry |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/412,229 Continuation US20170127984A1 (en) | 2014-03-13 | 2017-01-23 | System for monitoring body chemistry |
Publications (1)
Publication Number | Publication Date |
---|---|
US20170086713A1 true US20170086713A1 (en) | 2017-03-30 |
Family
ID=54067615
Family Applications (11)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/657,924 Abandoned US20150257685A1 (en) | 2014-03-13 | 2015-03-13 | System for monitoring body chemistry |
US14/657,973 Abandoned US20150257687A1 (en) | 2014-03-13 | 2015-03-13 | System for monitoring body chemistry |
US15/377,318 Abandoned US20170086713A1 (en) | 2014-03-13 | 2016-12-13 | System for monitoring body chemistry |
US15/412,229 Abandoned US20170127984A1 (en) | 2014-03-13 | 2017-01-23 | System for monitoring body chemistry |
US15/876,678 Abandoned US20180140235A1 (en) | 2014-03-13 | 2018-01-22 | System for monitoring body chemistry |
US17/156,520 Active US11291390B2 (en) | 2014-03-13 | 2021-01-22 | Wearable microneedle patch |
US17/198,223 Active US11272866B2 (en) | 2014-03-13 | 2021-03-10 | Wearable microneedle patch |
US17/590,689 Pending US20220151519A1 (en) | 2014-03-13 | 2022-02-01 | System for monitoring body chemistry |
US17/590,673 Pending US20220151518A1 (en) | 2014-03-13 | 2022-02-01 | System for monitoring body chemistry |
US17/681,681 Pending US20220233107A1 (en) | 2014-03-13 | 2022-02-25 | System for monitoring body chemistry |
US17/681,669 Abandoned US20220175279A1 (en) | 2014-03-13 | 2022-02-25 | System for monitoring body chemistry |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/657,924 Abandoned US20150257685A1 (en) | 2014-03-13 | 2015-03-13 | System for monitoring body chemistry |
US14/657,973 Abandoned US20150257687A1 (en) | 2014-03-13 | 2015-03-13 | System for monitoring body chemistry |
Family Applications After (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/412,229 Abandoned US20170127984A1 (en) | 2014-03-13 | 2017-01-23 | System for monitoring body chemistry |
US15/876,678 Abandoned US20180140235A1 (en) | 2014-03-13 | 2018-01-22 | System for monitoring body chemistry |
US17/156,520 Active US11291390B2 (en) | 2014-03-13 | 2021-01-22 | Wearable microneedle patch |
US17/198,223 Active US11272866B2 (en) | 2014-03-13 | 2021-03-10 | Wearable microneedle patch |
US17/590,689 Pending US20220151519A1 (en) | 2014-03-13 | 2022-02-01 | System for monitoring body chemistry |
US17/590,673 Pending US20220151518A1 (en) | 2014-03-13 | 2022-02-01 | System for monitoring body chemistry |
US17/681,681 Pending US20220233107A1 (en) | 2014-03-13 | 2022-02-25 | System for monitoring body chemistry |
US17/681,669 Abandoned US20220175279A1 (en) | 2014-03-13 | 2022-02-25 | System for monitoring body chemistry |
Country Status (4)
Country | Link |
---|---|
US (11) | US20150257685A1 (en) |
EP (1) | EP3116397A4 (en) |
CN (1) | CN106102578A (en) |
WO (1) | WO2015138989A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190183339A1 (en) * | 2017-12-20 | 2019-06-20 | PercuSense, Inc. | System and method for disease risk assessment and treatment |
US20210137410A1 (en) * | 2014-12-15 | 2021-05-13 | Virginia Tech Intellectual Properties, Inc. | Intelligent surgical probe for real-time monitoring of electroporation-based therapies |
CN113040764A (en) * | 2019-12-27 | 2021-06-29 | 全康科技股份有限公司 | Wearable sensing device |
US11272866B2 (en) * | 2014-03-13 | 2022-03-15 | One Drop Biosensor Technologies, Llc | Wearable microneedle patch |
US11357430B2 (en) | 2014-03-13 | 2022-06-14 | One Drop Biosensor Technologies, Llc | Biomonitoring systems and methods of loading and releasing the same |
WO2022240700A1 (en) | 2021-05-08 | 2022-11-17 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
USD988882S1 (en) | 2021-04-21 | 2023-06-13 | Informed Data Systems Inc. | Sensor assembly |
US12011294B2 (en) | 2020-07-29 | 2024-06-18 | Biolinq Incorporated | Continuous analyte monitoring system with microneedle array |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3796332A1 (en) * | 2013-11-14 | 2021-03-24 | Dexcom, Inc. | Devices and methods for continuous analyte monitoring |
US20180338712A1 (en) * | 2014-07-17 | 2018-11-29 | Imperial Innovations Limited | Mutli-probe microstructured arrays |
US10321858B2 (en) * | 2014-08-18 | 2019-06-18 | Proteadx, Inc. | Apparatus and methods for transdermal sensing of analytes in interstitial fluid and associated data transmission systems |
TWM509629U (en) * | 2015-04-28 | 2015-10-01 | Cheng Uei Prec Ind Co Ltd | Detachable type of adhesive wear products |
US11166653B2 (en) | 2015-10-14 | 2021-11-09 | The Regents Of The University Of California | Reconfigurable, multi-technique electrochemical portable biosensor |
WO2017172391A1 (en) * | 2016-03-30 | 2017-10-05 | Dexcom, Inc. | Systems, devices and methods for analyte monitoring system |
IT201700002389A1 (en) * | 2017-01-12 | 2017-04-12 | Matteo Giuseppe Cimmino | MONITORING DEVICE FOR LEVELS OF GLUCOSE IN THE BODY. |
US11045142B1 (en) | 2017-04-29 | 2021-06-29 | Biolinq, Inc. | Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry |
US11311225B2 (en) * | 2017-07-11 | 2022-04-26 | General Electric Company | Systems and methods for shielded and adjustable medical monitoring devices |
WO2019014478A1 (en) * | 2017-07-12 | 2019-01-17 | Maximum Integrated Products, Inc. | Test device and system for analyzing fluid samples |
EP3603489A1 (en) * | 2018-08-03 | 2020-02-05 | PKvitality | Body monitoring system with removable connection |
US12048558B2 (en) | 2018-10-02 | 2024-07-30 | WearOptimo Pty Ltd | System for determining fluid level in a biological subject |
WO2020102277A1 (en) * | 2018-11-13 | 2020-05-22 | University Of Cincinnati | Quality assurance of collected interstitial fluid samples |
CN109827898B (en) * | 2019-03-29 | 2021-09-17 | 河海大学 | Metal corrosion test device |
US20230053962A1 (en) * | 2019-10-01 | 2023-02-23 | WearOptimo Pty Ltd | Analyte measurement system |
WO2021158193A1 (en) * | 2020-02-04 | 2021-08-12 | Cukurova Universitesi Rektorlugu | Blood gas measuring device |
WO2021216744A2 (en) | 2020-04-21 | 2021-10-28 | Informed Data Systems Inc. D/B/A One Drop | Systems and methods for biomonitoring and providing personalized healthcare |
CN111543963B (en) * | 2020-05-14 | 2020-11-10 | 清华大学 | Multifunctional flexible sensor patch and preparation method thereof |
WO2021247928A1 (en) | 2020-06-03 | 2021-12-09 | Informed Data Systems Inc. D/B/A One Drop | Systems for adaptive healthcare support, behavioral intervention, and associated methods |
EP4167853A4 (en) * | 2020-06-17 | 2024-07-03 | Biolinq Inc | Devices and methods for application of microneedle arrays |
FR3117766A1 (en) | 2020-12-21 | 2022-06-24 | Pkvitality | BODY MONITORING DEVICE WITH EXTENDED DETECTION RANGE |
WO2022159403A1 (en) | 2021-01-19 | 2022-07-28 | Informed Data Systems Inc. D/B/A One Drop | Systems and methods for tracking and calibrating biosensors |
WO2022170283A1 (en) | 2021-02-08 | 2022-08-11 | Informed Data Systems Inc. | Biosensor excitation methods, and associated systems, devices, and methods |
FR3120623B1 (en) | 2021-03-09 | 2023-04-21 | Pkvitality | METHOD FOR ETCHING A HOLE AND METHOD FOR MANUFACTURING A MICRO-NEEDLE USING SUCH A HOLE |
WO2022241273A1 (en) | 2021-05-14 | 2022-11-17 | Informed Data Systems Inc. D/B/A One Drop | Wearable blood pressure biosensors, systems and methods for short-term blood pressure prediction |
US11684298B2 (en) | 2021-07-07 | 2023-06-27 | The Regents Of The University Of California | Wearable, non-intrusive microneedle sensor |
US12004874B2 (en) | 2022-10-24 | 2024-06-11 | Applied Cognition, Inc. | Wearable device and method for non-invasive assessment of glymphatic flow |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040260241A1 (en) * | 2003-03-26 | 2004-12-23 | Terumo Kabushiki Kaisha | Catheter with puncture sensor |
US20070208245A1 (en) * | 2003-08-01 | 2007-09-06 | Brauker James H | Transcutaneous analyte sensor |
US20100113897A1 (en) * | 2007-03-19 | 2010-05-06 | Bayer Health Care Llc | Continuous analyte monitoring assembly and methods of using the same |
US20110125058A1 (en) * | 2009-11-24 | 2011-05-26 | Seven Sense Biosystems, Inc. | Patient-enacted sampling technique |
US20110257495A1 (en) * | 2009-02-26 | 2011-10-20 | Abbott Diabetes Care Inc. | Analyte Monitoring Device and Methods |
US20120078071A1 (en) * | 2010-09-29 | 2012-03-29 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
US20120265042A1 (en) * | 2005-11-11 | 2012-10-18 | Isense Corporation | Method and apparatus for insertion of a sensor |
US20130225956A1 (en) * | 2011-09-23 | 2013-08-29 | National Taipei University Of Technology | Transdermal Sensor |
US20130331676A1 (en) * | 2012-06-08 | 2013-12-12 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
Family Cites Families (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS495906B1 (en) | 1969-01-17 | 1974-02-09 | ||
JPS5021115B1 (en) | 1970-10-06 | 1975-07-19 | ||
GB1417702A (en) | 1972-03-03 | 1975-12-17 | Gkn Transmissions Ltd | Injectors for fuel injection apparatus |
JPS5241639A (en) | 1975-09-30 | 1977-03-31 | Mitsubishi Mining & Cement Co | Process for utilization of alkaliiresistant glass fiber reinforced cement scrap |
US5949739A (en) | 1987-08-31 | 1999-09-07 | Reese; Sudha S. | Sonar bearing estimation of extended targets |
US4953552A (en) | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
US5215088A (en) | 1989-11-07 | 1993-06-01 | The University Of Utah | Three-dimensional electrode device |
GB9304306D0 (en) | 1993-03-03 | 1993-04-21 | Univ Alberta | Glucose sensor |
KR0138307B1 (en) | 1994-12-14 | 1998-06-01 | 김광호 | Method of fabricating side contact in semiconductor device |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US6699667B2 (en) | 1997-05-14 | 2004-03-02 | Keensense, Inc. | Molecular wire injection sensors |
US7267665B2 (en) * | 1999-06-03 | 2007-09-11 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
JP2002505008A (en) | 1997-06-16 | 2002-02-12 | エラン コーポレーション ピーエルシー | Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods |
US6001239A (en) | 1998-09-30 | 1999-12-14 | Mercury Diagnostics, Inc. | Membrane based electrochemical test device and related methods |
CO5040209A1 (en) | 1997-10-16 | 2001-05-29 | Abbott Lab | BIOSENSOR ELECTRODES MEDIATORS OF COFACTOR REGENERATION |
US20060015058A1 (en) | 1998-01-08 | 2006-01-19 | Kellogg Scott C | Agents and methods for enhancement of transdermal transport |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
GB2337122B (en) | 1998-05-08 | 2002-11-13 | Medisense Inc | Test strip |
PT1077636E (en) | 1998-05-13 | 2004-06-30 | Cygnus Therapeutic Systems | SIGNAL PROCESSING FOR PHYSIOLOGICAL ANALYZES MEDICATION |
US6424847B1 (en) | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
US6743211B1 (en) | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
AU5461300A (en) | 1999-06-04 | 2000-12-28 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
GB9924160D0 (en) | 1999-10-12 | 1999-12-15 | Bwe Ltd | Continuous extrusion apparatus |
US6895263B2 (en) | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
CN100457887C (en) | 2000-05-03 | 2009-02-04 | 高振智 | Biological identification system with integrated sensor chip |
US6540675B2 (en) | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
US6690959B2 (en) | 2000-09-01 | 2004-02-10 | Medtronic, Inc. | Skin-mounted electrodes with nano spikes |
JP2002098639A (en) | 2000-09-21 | 2002-04-05 | Olympus Optical Co Ltd | Image data acquisition method |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
EP1364396A4 (en) | 2001-02-05 | 2005-08-31 | Becton Dickinson Co | Microprotrusion array and methods of making a microprotrusion |
US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
US6790179B2 (en) | 2001-08-01 | 2004-09-14 | Johnson & Johnson Consumer Companies, Inc. | Method of examining and diagnosing skin health |
US6872297B2 (en) | 2001-05-31 | 2005-03-29 | Instrumentation Laboratory Company | Analytical instruments, biosensors and methods thereof |
US6793632B2 (en) | 2001-06-12 | 2004-09-21 | Lifescan, Inc. | Percutaneous biological fluid constituent sampling and measurement devices and methods |
US6837988B2 (en) | 2001-06-12 | 2005-01-04 | Lifescan, Inc. | Biological fluid sampling and analyte measurement devices and methods |
US6501976B1 (en) | 2001-06-12 | 2002-12-31 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
US7344507B2 (en) * | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US6875613B2 (en) | 2001-06-12 | 2005-04-05 | Lifescan, Inc. | Biological fluid constituent sampling and measurement devices and methods |
US6863833B1 (en) | 2001-06-29 | 2005-03-08 | The Board Of Trustees Of The Leland Stanford Junior University | Microfabricated apertures for supporting bilayer lipid membranes |
US6749792B2 (en) | 2001-07-09 | 2004-06-15 | Lifescan, Inc. | Micro-needles and methods of manufacture and use thereof |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
WO2003024507A2 (en) | 2001-09-19 | 2003-03-27 | Biovalve Technologies, Inc. | Microneedles, microneedle arrays, and systems and methods relating to same |
WO2003035279A1 (en) | 2001-10-19 | 2003-05-01 | Superior Micropowders Llc | Tape compositions for the deposition of electronic features |
US20040060902A1 (en) | 2002-02-05 | 2004-04-01 | Evans John D. | Microprotrusion array and methods of making a microprotrusion |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US7146202B2 (en) | 2003-06-16 | 2006-12-05 | Isense Corporation | Compound material analyte sensor |
US7366556B2 (en) | 2003-12-05 | 2008-04-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
WO2005060621A2 (en) | 2003-11-21 | 2005-07-07 | The Regents Of The University Of California | Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles |
EP3263032B1 (en) * | 2003-12-09 | 2024-01-24 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
EP1734858B1 (en) | 2004-03-22 | 2014-07-09 | BodyMedia, Inc. | Non-invasive temperature monitoring device |
US20070027383A1 (en) | 2004-07-01 | 2007-02-01 | Peyser Thomas A | Patches, systems, and methods for non-invasive glucose measurement |
US7640048B2 (en) | 2004-07-13 | 2009-12-29 | Dexcom, Inc. | Analyte sensor |
US7654956B2 (en) | 2004-07-13 | 2010-02-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060016700A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060094945A1 (en) | 2004-10-28 | 2006-05-04 | Sontra Medical Corporation | System and method for analyte sampling and analysis |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
EP1869414A4 (en) | 2005-03-29 | 2010-07-28 | Arkal Medical Inc | Devices, systems, methods and tools for continuous glucose monitoring |
EP1874179A2 (en) | 2005-04-25 | 2008-01-09 | Infotonics Technology Center, Inc. | Microneedle with glucose sensor and method thereof |
US20070004989A1 (en) | 2005-06-29 | 2007-01-04 | Parvinder Dhillon | Device for transdermal sampling |
US8882670B2 (en) | 2005-07-06 | 2014-11-11 | Credent Medical Limited | Apparatus and method for measuring constituent concentrations within a biological tissue structure |
US20070292855A1 (en) * | 2005-08-19 | 2007-12-20 | Intel Corporation | Method and CMOS-based device to analyze molecules and nanomaterials based on the electrical readout of specific binding events on functionalized electrodes |
US20070173706A1 (en) * | 2005-11-11 | 2007-07-26 | Isense Corporation | Method and apparatus for insertion of a sensor |
US20090036794A1 (en) | 2005-12-29 | 2009-02-05 | Rikshospitalet-Radiumhospitalet Hf | Method and apparatus for determining local tissue impedance for positioning of a needle |
US8114269B2 (en) | 2005-12-30 | 2012-02-14 | Medtronic Minimed, Inc. | System and method for determining the point of hydration and proper time to apply potential to a glucose sensor |
CN101394878A (en) * | 2006-02-09 | 2009-03-25 | 德卡产品有限公司 | Peripheral systems |
EP2338548B1 (en) | 2006-02-09 | 2013-05-29 | DEKA Products Limited Partnership | Fluid delivery systems |
US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US8478557B2 (en) | 2009-07-31 | 2013-07-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US7951300B2 (en) | 2006-07-17 | 2011-05-31 | University Of Utah Research Foundation | Water-scale needle array |
US8865288B2 (en) | 2006-07-17 | 2014-10-21 | University Of Utah Research Foundation | Micro-needle arrays having non-planar tips and methods of manufacture thereof |
US20080058726A1 (en) | 2006-08-30 | 2008-03-06 | Arvind Jina | Methods and Apparatus Incorporating a Surface Penetration Device |
ATE486521T1 (en) | 2007-03-23 | 2010-11-15 | Hoffmann La Roche | METHOD AND GLUCOSE MONITORING SYSTEM FOR MONITORING INDIVIDUAL METABOLIC REACTIONS |
MY148326A (en) | 2007-04-04 | 2013-03-29 | Exxonmobil Chem Patents Inc | Process and apparatus for para-xylene production |
US8386027B2 (en) | 2007-04-27 | 2013-02-26 | Echo Therapeutics, Inc. | Skin permeation device for analyte sensing or transdermal drug delivery |
US8080385B2 (en) | 2007-05-03 | 2011-12-20 | Abbott Diabetes Care Inc. | Crosslinked adduct of polyaniline and polymer acid containing redox enzyme for electrochemical sensor |
WO2008148067A2 (en) | 2007-05-24 | 2008-12-04 | Hmicro, Inc. | An integrated wireless sensor for physiological monitoring |
DK2006786T3 (en) | 2007-06-18 | 2018-08-06 | Hoffmann La Roche | Method and glucose monitoring system to monitor individual metabolic response and to generate nutrient feedback |
US7739551B2 (en) | 2007-06-20 | 2010-06-15 | Microsoft Corporation | Web page error reporting |
WO2008157820A1 (en) | 2007-06-21 | 2008-12-24 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US20120046533A1 (en) | 2007-08-29 | 2012-02-23 | Medtronic Minimed, Inc. | Combined sensor and infusion sets |
WO2009036348A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Medical device automatic start-up upon contact to patient tissue |
US7783442B2 (en) | 2007-10-31 | 2010-08-24 | Medtronic Minimed, Inc. | System and methods for calibrating physiological characteristic sensors |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8268604B2 (en) | 2007-12-20 | 2012-09-18 | Abbott Point Of Care Inc. | Compositions for forming immobilized biological layers for sensing |
US8241697B2 (en) | 2007-12-20 | 2012-08-14 | Abbott Point Of Care Inc. | Formation of immobilized biological layers for sensing |
US20100010601A1 (en) | 2008-01-07 | 2010-01-14 | Sandeep Negi | Self-Aligning Latch-up Mechanism in Out of Plane Silicon Microelectrode Arrays |
EP2271384B1 (en) * | 2008-03-10 | 2018-04-18 | Roche Diabetes Care GmbH | Portable infusion and sensing device with battery charging and data transferring mechanisms |
US20090301994A1 (en) | 2008-05-12 | 2009-12-10 | Rajmohan Bhandari | Methods for Wafer Scale Processing of Needle Array Devices |
CA2760680A1 (en) | 2008-05-23 | 2009-11-26 | The University Of Queensland | Analyte detection by microneedle patch with analyte selective reagents |
US20090294307A1 (en) | 2008-06-02 | 2009-12-03 | Zenghe Liu | Redox polymer based reference electrodes having an extended lifetime for use in long term amperometric sensors |
WO2009149197A2 (en) | 2008-06-03 | 2009-12-10 | University Of Utah Research Foundation | High aspect ratio microelectrode arrays enabled to have customizable lengths and methods of making the same |
US8700114B2 (en) | 2008-07-31 | 2014-04-15 | Medtronic Minmed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US8886334B2 (en) | 2008-10-07 | 2014-11-11 | Mc10, Inc. | Systems, methods, and devices using stretchable or flexible electronics for medical applications |
US20110150765A1 (en) | 2008-10-31 | 2011-06-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Frozen compositions and methods for piercing a substrate |
US20100198034A1 (en) * | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
ES2884623T3 (en) | 2009-07-23 | 2021-12-10 | Abbott Diabetes Care Inc | Manufacturing procedure and continuous analyte measurement system |
CA2765712A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
US20110060202A1 (en) | 2009-09-08 | 2011-03-10 | Seth Adrian Miller | Dehydration detector using micro-needles |
EP2482724A2 (en) | 2009-09-30 | 2012-08-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
EP2496936B1 (en) * | 2009-10-16 | 2018-02-21 | Microchips Biotech, Inc. | Multi-channel potentiostat for biosensor arrays and method of operation |
WO2011051922A2 (en) | 2009-11-02 | 2011-05-05 | Università Degli Studi Di Padova | Method to recalibrate continuous glucose monitoring data on-line |
US9089292B2 (en) | 2010-03-26 | 2015-07-28 | Medtronic Minimed, Inc. | Calibration of glucose monitoring sensor and/or insulin delivery system |
US20120238841A1 (en) | 2010-04-15 | 2012-09-20 | Mark Castle | Sample capture in one step for test strips |
US9215995B2 (en) | 2010-06-23 | 2015-12-22 | Medtronic Minimed, Inc. | Sensor systems having multiple probes and electrode arrays |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US9662047B2 (en) | 2010-08-05 | 2017-05-30 | Massachusetts Institute Of Technology | Portable raman diagnostic system |
GB201019577D0 (en) | 2010-11-18 | 2010-12-29 | Univ Cork | Method |
GB2500550A (en) * | 2010-12-16 | 2013-09-25 | Sensor Innovations Inc | Electrochemical sensors |
US20120165639A1 (en) | 2010-12-22 | 2012-06-28 | Roche Diagnostics Operations, Inc. | Storage of calibration data at a continuous glucose monitor |
US8808532B2 (en) | 2011-01-20 | 2014-08-19 | Medtronic Minimed, Inc | Electrode compositions for use with analyte sensors |
US9195799B2 (en) * | 2011-02-08 | 2015-11-24 | Aulisa Medtech International, Inc. | Wireless patient monitoring system |
US20130338598A1 (en) | 2011-02-09 | 2013-12-19 | Unomedical A/S | Removal of Cannula Part from Base Part |
EP2672903A4 (en) * | 2011-02-10 | 2017-07-12 | Actuated Medical, Inc. | Medical tool with electromechanical control and feedback |
WO2012108939A1 (en) | 2011-02-11 | 2012-08-16 | Abbott Diabetes Care Inc. | Feedback from cloud or hcp to payer or patient via meter or cell phone |
WO2012108938A1 (en) | 2011-02-11 | 2012-08-16 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
JP5837570B2 (en) | 2011-03-25 | 2015-12-24 | テルモ株式会社 | Body fluid component measurement system |
EP3407064B1 (en) | 2011-08-03 | 2020-04-22 | Intuity Medical, Inc. | Body fluid sampling arrangement |
KR101542549B1 (en) | 2011-09-02 | 2015-08-06 | 산디아 코포레이션 | Microneedle arrays for biosensing and drug delivery |
JP6443802B2 (en) | 2011-11-07 | 2018-12-26 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | Analyte monitoring apparatus and method |
DK4056105T3 (en) | 2011-12-11 | 2024-01-02 | Abbott Diabetes Care Inc | Analyte sensor devices |
US20130178726A1 (en) | 2012-01-05 | 2013-07-11 | Medtronic Minimed, Inc. | Stabilized polymers for use with analyte sensors and methods for making and using them |
US10694983B2 (en) | 2012-01-19 | 2020-06-30 | Medtronic Minimed, Inc. | Method and/or system for assessing a patient's glycemic response |
US9433376B2 (en) * | 2012-03-16 | 2016-09-06 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US20130267812A1 (en) | 2012-04-04 | 2013-10-10 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US20130280696A1 (en) | 2012-04-23 | 2013-10-24 | Elliott Millenson | Devices and methods for detecting analyte in bodily fluid |
US20140012117A1 (en) | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
TWM444565U (en) | 2012-08-03 | 2013-01-01 | Kuo-Yuan Chang | Electronic vital-sign system with manually entering vital-sign data function |
US9504411B2 (en) | 2012-08-28 | 2016-11-29 | Roche Diabetes Care, Inc. | Diabetes manager for glucose testing and continuous glucose monitoring |
US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
US9211092B2 (en) | 2013-01-03 | 2015-12-15 | Dexcom, Inc. | End of life detection for analyte sensors |
US10820860B2 (en) | 2013-03-14 | 2020-11-03 | One Drop Biosensor Technologies, Llc | On-body microsensor for biomonitoring |
CN105228522B (en) | 2013-03-14 | 2018-06-26 | 萨诺智能公司 | For the microsensor on the human body of biological monitoring |
CA2902234A1 (en) | 2013-03-15 | 2014-09-18 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US20140275898A1 (en) | 2013-03-15 | 2014-09-18 | Abbott Diabetes Care Inc. | Medical Device Data Processing and Communication Methods and Systems |
EP3016586B1 (en) * | 2013-07-01 | 2020-06-17 | Mayo Foundation for Medical Education and Research | Advanced health monitoring system |
WO2015017561A1 (en) | 2013-07-30 | 2015-02-05 | Zosano Pharma, Inc. | Low-profile microneedle patch applicator |
EP3089665A4 (en) | 2013-12-31 | 2017-09-20 | Senseonics, Incorporated | Continuous analyte monitoring system |
US10166143B2 (en) | 2013-12-31 | 2019-01-01 | Ip Liberty Vision Corporation | Versatile light-guided ophthalmic treatment system |
TWI548395B (en) | 2014-01-28 | 2016-09-11 | 微凸科技股份有限公司 | Transdermal micrneedles continuous monitoring system |
US10595754B2 (en) | 2014-03-13 | 2020-03-24 | Sano Intelligence, Inc. | System for monitoring body chemistry |
US20150257685A1 (en) | 2014-03-13 | 2015-09-17 | Sano Intelligence, Inc. | System for monitoring body chemistry |
US20170172475A1 (en) | 2014-03-13 | 2017-06-22 | Sano Intelligence, Inc. | System for monitoring body chemistry |
EP2982302B1 (en) | 2014-08-05 | 2018-05-23 | Roche Diabetes Care GmbH | Medical applicator |
US10321858B2 (en) | 2014-08-18 | 2019-06-18 | Proteadx, Inc. | Apparatus and methods for transdermal sensing of analytes in interstitial fluid and associated data transmission systems |
US9974471B1 (en) | 2014-10-24 | 2018-05-22 | Verily Life Sciences Llc | Analyte detection system and method for intradermal implantation of biocompatible optode nanosensors |
US10631766B2 (en) | 2015-03-05 | 2020-04-28 | The Trustees Of Columbia University In The City Of New York | Devices and systems for optically determining a concentration of an analyte in a living subject using hydrogel-based, fluorescent microneedles and methods of manufacture thereof |
US10383558B2 (en) | 2015-03-06 | 2019-08-20 | Samsung Electronics Co., Ltd. | Device for measuring bio information and method for manufacturing the same |
US10874335B2 (en) | 2015-03-25 | 2020-12-29 | Samsung Electronics Co., Ltd | Wearable electronic device |
US10046114B1 (en) | 2015-05-22 | 2018-08-14 | Verily Life Sciences Llc | Control of a peripheral device with a bandage-type analyte sensor |
US10098574B1 (en) | 2015-07-07 | 2018-10-16 | Verily Life Sciences Llc | Porous microneedles through sacrificial sugar incorporation, analyte detection system, and method for intradermal optode nanosensor implantation |
PL3138489T3 (en) | 2015-09-02 | 2020-11-16 | F. Hoffmann-La Roche Ag | Kit for determining an analyte concentration |
HUE063560T2 (en) | 2015-12-30 | 2024-01-28 | Dexcom Inc | Transcutaneous analyte sensor systems and methods |
US10765369B2 (en) | 2016-04-08 | 2020-09-08 | Medtronic Minimed, Inc. | Analyte sensor |
US20200101286A1 (en) | 2016-05-15 | 2020-04-02 | Biolinq, Inc. | Devices And Methods For The Generation Of Alerts Due To Rising Levels Of Circulating Ketone Bodies In Physiological Fluids |
KR102693461B1 (en) | 2017-06-23 | 2024-08-07 | 덱스콤, 인크. | Transdermal analytical sensor, applicator therefor and related method |
US10524730B2 (en) | 2017-09-28 | 2020-01-07 | Medtronic Minimed, Inc. | Medical devices with microneedle arrays and methods for operating such medical devices |
TWI653968B (en) | 2017-11-20 | 2019-03-21 | 研能科技股份有限公司 | Blood glucose detecting device |
-
2015
- 2015-03-13 US US14/657,924 patent/US20150257685A1/en not_active Abandoned
- 2015-03-13 WO PCT/US2015/020586 patent/WO2015138989A1/en active Application Filing
- 2015-03-13 US US14/657,973 patent/US20150257687A1/en not_active Abandoned
- 2015-03-13 EP EP15762313.3A patent/EP3116397A4/en not_active Withdrawn
- 2015-03-13 CN CN201580012731.0A patent/CN106102578A/en active Pending
-
2016
- 2016-12-13 US US15/377,318 patent/US20170086713A1/en not_active Abandoned
-
2017
- 2017-01-23 US US15/412,229 patent/US20170127984A1/en not_active Abandoned
-
2018
- 2018-01-22 US US15/876,678 patent/US20180140235A1/en not_active Abandoned
-
2021
- 2021-01-22 US US17/156,520 patent/US11291390B2/en active Active
- 2021-03-10 US US17/198,223 patent/US11272866B2/en active Active
-
2022
- 2022-02-01 US US17/590,689 patent/US20220151519A1/en active Pending
- 2022-02-01 US US17/590,673 patent/US20220151518A1/en active Pending
- 2022-02-25 US US17/681,681 patent/US20220233107A1/en active Pending
- 2022-02-25 US US17/681,669 patent/US20220175279A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040260241A1 (en) * | 2003-03-26 | 2004-12-23 | Terumo Kabushiki Kaisha | Catheter with puncture sensor |
US20070208245A1 (en) * | 2003-08-01 | 2007-09-06 | Brauker James H | Transcutaneous analyte sensor |
US20120265042A1 (en) * | 2005-11-11 | 2012-10-18 | Isense Corporation | Method and apparatus for insertion of a sensor |
US20100113897A1 (en) * | 2007-03-19 | 2010-05-06 | Bayer Health Care Llc | Continuous analyte monitoring assembly and methods of using the same |
US20110257495A1 (en) * | 2009-02-26 | 2011-10-20 | Abbott Diabetes Care Inc. | Analyte Monitoring Device and Methods |
US20110125058A1 (en) * | 2009-11-24 | 2011-05-26 | Seven Sense Biosystems, Inc. | Patient-enacted sampling technique |
US20120078071A1 (en) * | 2010-09-29 | 2012-03-29 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
US20130225956A1 (en) * | 2011-09-23 | 2013-08-29 | National Taipei University Of Technology | Transdermal Sensor |
US20130331676A1 (en) * | 2012-06-08 | 2013-12-12 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357430B2 (en) | 2014-03-13 | 2022-06-14 | One Drop Biosensor Technologies, Llc | Biomonitoring systems and methods of loading and releasing the same |
US11517222B2 (en) | 2014-03-13 | 2022-12-06 | One Drop Biosensor Technologies, Llc | Biomonitoring systems and methods of loading and releasing the same |
US11272866B2 (en) * | 2014-03-13 | 2022-03-15 | One Drop Biosensor Technologies, Llc | Wearable microneedle patch |
US11291390B2 (en) | 2014-03-13 | 2022-04-05 | One Drop Biosensor Technologies, Llc | Wearable microneedle patch |
US20210137410A1 (en) * | 2014-12-15 | 2021-05-13 | Virginia Tech Intellectual Properties, Inc. | Intelligent surgical probe for real-time monitoring of electroporation-based therapies |
WO2019126397A1 (en) * | 2017-12-20 | 2019-06-27 | Percusense | System and method for disease risk assessment and treatment |
US11529053B2 (en) * | 2017-12-20 | 2022-12-20 | PercuSense, Inc. | System and method for disease risk assessment and treatment |
US20190183339A1 (en) * | 2017-12-20 | 2019-06-20 | PercuSense, Inc. | System and method for disease risk assessment and treatment |
EP3841975A1 (en) * | 2019-12-27 | 2021-06-30 | RichHealth Technology Corporation | Wearable sensing device |
EP3841963A1 (en) * | 2019-12-27 | 2021-06-30 | RichHealth Technology Corporation | Wearable sensing device |
CN113040764A (en) * | 2019-12-27 | 2021-06-29 | 全康科技股份有限公司 | Wearable sensing device |
TWI832001B (en) * | 2019-12-27 | 2024-02-11 | 全康科技股份有限公司 | Wearable sensing device |
US12011294B2 (en) | 2020-07-29 | 2024-06-18 | Biolinq Incorporated | Continuous analyte monitoring system with microneedle array |
USD988882S1 (en) | 2021-04-21 | 2023-06-13 | Informed Data Systems Inc. | Sensor assembly |
USD1038788S1 (en) | 2021-04-21 | 2024-08-13 | One Health Biosensing Inc. | Sensor assembly |
WO2022240700A1 (en) | 2021-05-08 | 2022-11-17 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
EP4153276A4 (en) * | 2021-05-08 | 2023-11-08 | Biolinq, Inc. | Fault detection for microneedle array based continuous analyte monitoring device |
US11857344B2 (en) | 2021-05-08 | 2024-01-02 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
Also Published As
Publication number | Publication date |
---|---|
US20210204845A1 (en) | 2021-07-08 |
US20220233107A1 (en) | 2022-07-28 |
EP3116397A4 (en) | 2017-11-01 |
EP3116397A1 (en) | 2017-01-18 |
US20220175279A1 (en) | 2022-06-09 |
CN106102578A (en) | 2016-11-09 |
US11291390B2 (en) | 2022-04-05 |
US20210275097A1 (en) | 2021-09-09 |
US20220151519A1 (en) | 2022-05-19 |
US20220151518A1 (en) | 2022-05-19 |
US20150257685A1 (en) | 2015-09-17 |
US11272866B2 (en) | 2022-03-15 |
WO2015138989A1 (en) | 2015-09-17 |
US20170127984A1 (en) | 2017-05-11 |
US20180140235A1 (en) | 2018-05-24 |
US20150257687A1 (en) | 2015-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11291390B2 (en) | Wearable microneedle patch | |
US11172851B2 (en) | System for monitoring body chemistry | |
ES2974786T3 (en) | Continuous Analyte Monitoring System with Microneedle Array | |
EP3389491B1 (en) | Data backfilling for continuous glucose monitoring | |
US11612363B2 (en) | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems | |
US10169539B2 (en) | Data backfilling for continuous glucose monitoring | |
US20170172475A1 (en) | System for monitoring body chemistry | |
US20230301552A1 (en) | Continuous cortisol monitoring system with microneedle array | |
CA3123936A1 (en) | Systems, devices, and methods for improved meal and therapy interfaces in analyte monitoring systems | |
CA3178307A1 (en) | Systems, devices, and methods for improved analyte sensor accuracy and fault detection | |
JP7510409B2 (en) | Systems, Apparatus, and Methods for Sensor Fault Detection - Patent application | |
US20240206772A1 (en) | Systems, devices, and methods for dual analyte sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SANO INTELLIGENCE, INC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PUSHPALA, ASHWIN;CHAPMAN, MATTHEW;SZMODIS, ALAN;AND OTHERS;SIGNING DATES FROM 20150319 TO 20150417;REEL/FRAME:040724/0681 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ONE DROP BIOSENSOR TECHNOLOGIES, LLC, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SANO INTELLIGENCE, INC.;REEL/FRAME:052246/0992 Effective date: 20200327 |
|
AS | Assignment |
Owner name: ONE HEALTH BIOSENSING INC., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ONE DROP BIOSENSOR TECHNOLOGIES, LLC;REEL/FRAME:066970/0874 Effective date: 20240319 |